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Abstract
A bioconversion is a stereospecific chemical transformation using whole cells such as
bacteria as the catalyst for the reaction(s). Bioconversions are commonly used in industrial
production of compounds such as antibiotics, vitamins, and precursors to therapeutics.
Bacteria from the genus Rhodococcus have been shown to be hardy, solvent tolerant, and an
excellent source of stereospecific enzymes. Therefore, Rhodococci are ideal candidates for
bioconversions. Rhodococcus strain 124 was identified by its ability to utilize aromatic
hydrocarbons such as naphthalene and toluene as sole carbon sources. This strain can
perform a bioconversion of the aromatic hydrocarbon indene to two enantiomers of 1,2-
indandiol that can be used in the synthesis of the HIV-1 protease inhibitor CrixivanTM. The
bioconversion of indene by Rhodococcus strain 124 is a complex network modeled as three
parallel pathways that produces a variety of indene derived compounds. Metabolic engineering,
the use of genetic engineering combined with chemical engineering, can be used to analyze
this bioconversion process. In this work the genetic engineering aspects of metabolic
engineering are described. The indene bioconversion pathways were analyzed genetically and
biochemically. We cloned and sequenced genes encoding one branch of the indene
bioconversion network. This branch, encoded by the genes nidABC, includes a naphthalene-
like dioxygenase system (nidAB) and a diol dehydrogenase (nidC). The NidAB dioxygenase
can catalyze the conversion of indene to cis-(1 R,2S)-indandiol, 1 -indenol, and 1 -indandone.
The NidC dehydrogenase can oxidize cis-(1 R,2S)-indandiol to keto-hydroxy-indan. Biochemical
analysis of the dehydrogenase activity demonstrated that the NidC dehydrogenase is
stereospecific for cis-(1 R,2S)-indandiol. Since we were interested in dissecting the indene
bioconversion network, the properties of a nidC null mutant were investigated. Results from
these analyses suggest the presence of a second diol dehydrogenase that is naphthalene-
inducible in Rhodococcus strain 124 capable of utilizing cis-(1 R,2S)-indandiol as a substrate.
The impact of these data on our model for the indene bioconversion network is discussed. The
genetic analysis of this system serves as a framework for the genetic engineering component of
metabolic engineering.
Thesis Supervisor: Anthony J. Sinskey
Title: Professor of Microbiology
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Chapter One: Introduction
Human Immunodeficiency Virus, HIV-1
The human immunodeficiency virus (HIV-1), previously called human T-cell leukemia/lymphoma virus
IlIl (HTLV-ll), was first discovered in the early 1980's (Barre-Sinoussi et al. 1983; Gallo et al. 1983;
Sarngadharan et al. 1984). This retrovirus is responsible for the symptoms associated with Acquired
Immunodeficiency Syndrome, better known as AIDS. HIV-1 infection has become prevalent worldwide
and AIDS has become a pandemic. Over the last fifteen years the HIV-1 retrovirus has been extensively
studied at the molecular level to better understand the virus, its components and the mechanism of
pathogenesis. Consequently, drugs capable of combating the virus have been developed based on our
understanding of the viral components and the viral life cycle.
Genome Structure and Life Cycle of HIV-1
Retroviruses are distinguished from other viruses by the presence of an RNA genome that is reverse-
transcribed by viral enzymes and integrated into the host DNA. There are two types of retroviruses,
simple and complex; HIV-1 is categorized as a complex retrovirus. Complex retroviruses are
distinguished from the simple viruses because they have regulatory factors such as transcription
activators and other factors that enhance/assist at different stages of the viral life cycle. The genome of
the HIV-1 virus was sequenced in 1984 by two separate groups and found to be approximately 10 kb in
length (Hahn et al. 1984; Luciw et al. 1984). Since then numerous laboratories have analyzed the
genome and its constituent parts in great detail (for detailed reviews see (Frankel and Young 1998; Katz
and Skalka 1994; Klotman and Wong-Staal 1991)). A model for the organization of the viral genome and
the relation of these parts to the assembled viral particle is depicted in Figure 1-1. The HIV-1 genome has
three major open reading frames called gag, pol, and env that encode the structural components. These
open reading frames produce the three major polyproteins produced by the virus, the Gag polyprotein, the
Gag-Pol polyprotein, and the Env polyprotein. These polyproteins are cleaved during the life cycle of the
virus to produce the major components of the virus. The Gag polyprotein contains the matrix protein
(MA), the capsid protein (CA), the nucleocapsid (NC), and a fourth protein called p6. The Gag-Pol
polyprotein produces the protease (PR), the reverse transcriptase (RT), and the integrase (IN). The Env
polyprotein produces two components of a membrane protein, the surface protein (SU/gpl 20) and the
transmembrane protein (TM/gp4l). In addition to the structural components and viral enzymes produced
from the polyproteins, the genome also encodes a number of regulatory factors including Tat, Rev, Nef,
Vif, Vpr, and Vpu.
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Figure 1-1: HIV-1 Genome Structure and Virus Particle Structure
A) The HIV-1 genome structure based on sequence information and molecular analysis of the
components. Three major open reading frames (gag, pol, and env) encode the major structural
components and enzymes. The regulatory and auxiliary factors are encoded separately and many
are the result of splicing events of the mRNA. The symbols of the proteins in the major open
reading frames are matrix (MA), capsid (CA), nucleocapsid (NC), p6, protease (PR), reverse
transcriptase (RT), integrase (IN), surface protein (SU) and transmembrane protein (TM) B)
Structure of the HIV-1 virion particle. The membrane is derived from the host cell during budding
of the immature virus particle.
The life cycle of the retrovirus is depicted in Figure 1-2 and can be broken down into three sections:
virus entry, replication, and virus packaging and maturation. The life cycle begins with virus entry into the
host cell. In the case of HIV-1 the host cell is either a T cell or a macrophage. The surface protein (SU)
binds to receptors (CD4) and co-receptors (chemokine receptors) on the host cell surface. After binding,
the transmembrane protein (TM) undergoes a conformational change that promotes cell fusion. The outer
membrane of the virus particle is removed exposing the virion core and the RNA is converted to partially
double stranded DNA by the reverse transcriptase (RT). The core is then transported across the nuclear
membrane with assistance from the integrase enzyme (IN) and the auxiliary protein Vpr. After entry into
the nucleus the integrase catalyzes the integration of the viral derived DNA into the host chromosome.
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The next stage of the life cycle is replication of the virus which begins with the production of viral
transcripts using the host cell's RNA polymerase II from the promoter of the viral genome found in the 5'-
long terminal repeat (LTR). Transcription is greatly enhanced by the transcription activator Tat that binds
the Tat Activating Region (TAR) found in the promoter. The RNA can remain whole producing mRNA that
will give rise to the Gag polyprotein, the Gag-Pol polyprotein or the RNA for the new viral particles. In
addition, the RNA can also be spliced to produce mRNA for the Env polyprotein and mRNAs for the
various auxiliary proteins. This stage is completed when the RNA is transported out of the nucleus and
into the cytoplasm. Transport is regulated by the auxiliary protein Rev.
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Figure 1-2: HIV-1 Life Cycle
The life cycle of the virus is depicted starting from virus entry into the cell (based on diagrams
from (Frankel and Young 1998; Katz and Skalka 1994; Klotman and Wong-Staal 1991)).
Auxiliary proteins (AUX) include the transcription activator Tat, the regulator Rev, and other
factors including Vpu, Vpr, Vif, and Nef.
The final stage, virus packaging and maturation, begins with the translation of the mRNAs into the
various proteins or polyproteins. The Env polyprotein is transferred to the endoplasmic reticulum and
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undergoes endoproteolytic cleavage to produce the two constituent proteins, the surface (SU) and
transmembrane (TM) proteins. A disulfide-bond associates the two proteins and the complex associates
with CD4 to target it to the cell surface. During provirus assembly the Vpu and Nef proteins promote
release of the surface protein complex from CD4. The Gag-Pol polyprotein is produced by a frameshift of
the ribosome during translation. The polyproteins Gag and Gag-Pol are targeted for assembly into the
provirus by packaging signals and are responsible for capturing the RNA for provirus packaging. During
provirus packaging a small quantity of protease, reverse transcriptase, and integrase are packaged into
the provirus. After packaging is complete, the provirus buds from the host cell and becomes a mature
virion when the polyproteins are cleaved by the protease (PR) producing the viral enzymes and capsid
components.
The HIV-1 Protease and Protease Inhibitors
The HIV-1 protease is a key enzyme in the maturation of the virus particle to its infectious state. The
protease is responsible for the cleavage of the polyprotein precursors of the major capsid proteins and
enzymes. It is an aspartyl protease that is similar to other aspartyl proteases such as renin and
endothiopepsin. The functional enzyme is a dimer with each monomer contributing the catalytic residues
(Asp-Thr/Ser-Gly) to the symmetric catalytic site. The protease uses a general acid-base mechanism and
cleaves between Tyr-Pro residues or Phe-Pro residues. No known consensus cleavage site has been
determined for retroviral proteases (Katz and Skalka 1994).
The protease is a prime target for drug therapy to combat HIV infection. Inhibition of the protease
should inhibit the life cycle of the virus by preventing virion maturation, thereby reducing the viral load in a
patient. It has been shown that chemical or mutational inactivation of the HIV-1 protease leads to the
production of immature, non-infectious virus particles (Kohl et al. 1988; McQuade et al. 1990; Seelmeier et
al. 1988). A number of protease inhibitors have been developed in the last ten years. These therapeutic
agents were produced in rational drug design efforts by a variety of companies using the structure of the
protease as a basis for their designs. Numerous crystal structures of the protease have been determined
of the protease alone and the protease complexed with other molecules (for review see (Wlodawer and
Vondrasek 1998)). Currently there are four protease inhibitors that have been approved for use by the
Food and Drug Administration (FDA). These structurally similar inhibitors include Saquinavir (Hoffman-La
Roche), Ritonavir (Abbott), Nelfinavir (Agouron Pharmaceuticals), and Indinavir (Merck) (Vacca and
Condra 1997).
Indinavir - A HIV- 1 Protease Inhibitor
Indinavir, also known as CrixivanTM, is one of four commercially available HIV-1 protease inhibitors. In
clinical trails this protease inhibitor is very effective in combination therapy with two reverse transcriptase
inhibitors, zidovudine and lamivudine (Hammer et al. 1997; Rutschmann and Hirschel 1997). The
structure of the inhibitor is shown in Figure 1-3 (Buckland et al. 1999). This inhibitor is a transition state
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analog that is reversible; it has also been called a peptidomimetic inhibitor. That is, the compound
resembles/mimics a certain state, the transition state, of the polyprotein during the cleavage reaction
(Wlodawer and Vondrasek 1998). Indinavir has five chiral centers; therefore, there are thirty-two possible
conformations of this compound. Only one of these confirmations is the active form of the therapeutic
agent. The compound is currently manufactured in a chemical synthesis by Merck and Company, Inc.
which requires numerous separate chemical steps. In each step involving a chiral center significant loss
of active product can occur (Buckland et al. 1999; Reider 1997).
h N QH
H
0TN 0H
Figure 1-3: Structure of the HIV-1 Protease Inhibitor CrixivanTm
The structure of the protease inhibitor indinavir sulfate is depicted above (Buckland et al. 1999).
An intermediate, cis-amino-indanol, in the synthesis of the compound is highlighted in black.
Chiral Synthesis of Therapeutics
Many therapeutics are chiral in nature and often only one enantiomer is active. Crixivan is one such
compound. Therefore, stereospecific synthesis is required to produce many therapeutic agents. Bacterial
enzymes can contribute to the chiral synthesis of therapeutic compounds or precursor molecules
(synthons). Enzymes from bacteria are often highly efficient and capable of carrying out stereospecific
reactions in a single step, where as a chemical synthesis may require multiple steps due to the protecting
and unprotecting of reactive centers. Bacterial enzymes have been used in two ways to produce chiral
synthons. One way is to isolate the bacterial enzyme and use it in an in vitro reaction. The second
method requires the use of whole cells in what is called a bioconversion. A bioconversion, also called a
biotransformation, is the process of using organisms such as bacteria to conduct chemical
transformations. Often the bioconversion substrate can not support growth of the organism.
There are numerous examples of drugs, vitamins, and precursor compounds that are produced using
a bioconversion at some stage in production. For example, vitamin C is produced by combining chemical
steps with a bioconversion in a genetically engineered strain of Acetobacter (Glazer and Nikaido 1995). A
precursor of the anti-inflammatory compound Naproxen is produced in a Bacillus subtilis bioconversion
(Patel 1997). Other compounds such as prednisone (a type of cortisone) (Primrose 1991), precursors to
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Taxol (Patel 1997; Zaks and Dodds 1997) and vitamin B-r (Zimmermann et al. 1997) also utilize
bioconversions in their synthesis.
It may be possible to produce a precursor to the HIV-1 protease inhibitor CrixivanTM using a
bioconversion process. The aromatic hydrocarbon indene could be used as the initial substrate for this
bioconversion. The hypothesized reactions necessary would be an oxygenation reaction and an amino-
transferase reaction (Figure 1-4). Two oxygenated versions of indene, cis-(1 S,2R)-indandiol and trans-
(1 R,2R)-indandiol, can be used as precursors for CrixivanTM (Buckland et al. 1999). The addition of the
amino group to these precursors could be conducted in an in vitro reaction, or possibly engineered into a
bioconverting strain. The first reaction (reaction A) that could produce these compounds could be
conducted by an oxygenase similar to those found in bacteria capable of degrading aromatic compounds.
Aromatic hydrocarbon metabolism/degradation has been extensively studied in bacteria.
QH
-- "210H LH 2
j iA cis-(l S,2R)-indandiol B ---"IIOH
amino-indanol
trans-(lR,2R)-indandiol
Figure 1-4: Potential bioconversion pathway for the synthesis of CrixivanTM
This pathway shows two routes to the intermediate amino-indanol. Enzyme A would be a type of
oxygenase. Enzyme B would be an amino-transferase. It is possible that a microbe could carry out
this bioconversion or part of this bioconversion naturally. Alternatively, a microbe could be
engineered to carry out this bioconversion.
Bacterial Aromatic Hydrocarbon Degradation
Aromatic hydrocarbon compound degradation/catabolism pathways in bacteria allow the organism to
utilize novel compounds as carbon sources rendering the bacteria capable of occupying numerous unique
environments. The first aromatic degrader, a strain of Bacillus haxacarbovorum, was identified in 1908 by
its ability to utilize toluene and xylene as carbon sources (for a historical review see (Gibson and
Subramanian 1984)). Over the years a wide range of Gram-negative and Gram-positive bacteria have
been identified that can metabolize many different aromatic hydrocarbons. Among these organisms are
Pseudomonas, Rhodococcus, Sphingomonas, and Alcaligenes, and Moraxella (Dagley 1971; Gibson and
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Subramanian 1984; Mueller et al. 1997; Warhurst and Fewson 1994). Strains have been found that can
degrade toluene, xylene, naphthalene, benzene, isopropyl benzene, chlorinated aromatic hydrocarbons
such as PCB's, and dibenzofuran among others (Bhat and Vaidyanathan 1995; Butler and Mason 1997;
Grund et al. 1995).
Aromatic compound degradation/catabolism can be carried out under aerobic conditions or anaerobic
conditions by very different pathways. Only aerobic pathways will be discussed here. Aerobic degradation
is comprised of two pathways, the upper pathway and the lower pathway (Kiyohara et al. 1994;
Sanseverino et al. 1993; Williams and Sayers 1994). Two example pathways containing an upper and a
lower pathway are shown in Figures 1-5 and 1-6. Figure 1-5 shows one route to metabolize toluene and
Figure 1-6 shows a pathway for naphthalene metabolism. The upper pathway consists of the first steps of
degradation through ring cleavage to produce catechol, a common intermediate of these pathways. An
oxygenase system (either a monooxygenase or dioxygenase) initiates the upper pathway, followed by an
oxidation step conducted by a dehydrogenase. The final portion of the upper pathway is a second
oxygenation by a different oxygenase that also catalyzes cleavage of the aromatic ring. If the compound
is a poly-aromatic compound, such as naphthalene, there will be multiple oxygenation and ring cleavage
steps in order to reach catechol (see Figure 1-6).
The lower pathway follows from the upper pathway by continuing to breakdown the ring-cleavage
product so that it may be ultimately used in primary carbon metabolism. The lower pathway can be
subcategorized into the meta pathway and the ortho pathway (also called the 0-ketoadipate pathway).
The type of lower pathway is dependent on the position of the ring-cleavage that occurs relative to the
recently added hydroxyl groups (Williams and Sayers 1994). As new strains of bacteria are identified and
studied, numerous aromatic hydrocarbon degradation/metabolism pathways have been elucidated. The
extensive study of these pathways allows for some generalizations about the components of these
pathways. Specifically, components of the upper pathway including oxygenases and dehydrogenases will
be discussed both biochemically and genetically. These enzymes could play a role in a putative
bioconversion of indene to produce a chiral synthon.
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Figure 1-5: Toluene Catabolism/degradation Pathway
One route for toluene catabolism by Pseudomonas putida is shown (Zylstra et al. 1988). The
upper and lower pathways are demarcated. The upper pathway contains a dioxygenase system
with multiple electron transport proteins (see below).
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Figure 1-6: Naphthalene Catabolism/degradation Pathway
Naphthalene catabolism Pseudomonas putida is shown (Zylstra 1994). This pathway has two
parts, an upper and a lower pathway. The upper pathway is extended and contains a dioxygenase
system with multiple electron transport proteins (see below). The lower pathway is marked with a
line.
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Oxygenases
There are two main types of oxygenases, monooxygenases and dioxygenases. In general,
monooxygenases incorporate one atom of oxygen from molecular oxygen and dioxygenases incorporate
both atoms of oxygen (Hayaishi 1962). Monooxygenases are also known as mixed function oxidases or
hydrolases (Hayaishi 1962; Mason 1988). The distinction between monooxygenases and dioxygenases,
however, is not always clear. There are examples of monooxygenases that oxygenate repeatedly
producing a product that appears to have resulted from a dioxygenation reaction (Lei and Tu 1996;
Oldfield et al. 1997). Furthermore, some dioxygenases have monooxygenation activities depending on
the substrate (Brand et al. 1992; Gibson et al. 1995; Lehning et al. 1997; Spain et al. 1989; Wackett et al.
1988). Consequently, the classification of oxygenases as monooxygenases or dioxygenases is only
suggestive of their function, but not their full potential as enzymes. In addition not only can oxygenases
add molecular oxygen, but they can dehalogenate simultaneously as in PCB degradation (chlorinated
aromatics) or degradation of other halogenated compounds (Fetzner 1998; Khan and Walia 1989), and
remove sulfur or nitrogen (Gray et al. 1996; Spain 1995).
There are many different types of oxygenases based upon the type of cofactors they employ. All
oxygenases contain a cofactors such as transition metals, heme, and/or flavin or pteridine that interact
with molecular oxygen (Harayama et al. 1992; Hayaishi 1962). For example, many oxygenases use Fe(II)
or Fe(Ill) as cofactors (Harayama et al. 1992). Other oxygenases such as the chlorocatechol 1,2-
dioxygenase from Rhodococcus erythropolis 1CP contain manganese as a cofactor (Maltseva et al.
1994), and a Pseudomonas L-tryptophan 2, 3-dioxygenase contains copper as the metal cofactor
(Feigelson 1976). They may also have iron-sulfur centers (2Fe-2S centers) in addition to metal cofactors
(Harayama et al. 1992). Those oxygenases that contain flavin as a cofactor are also called flavoproteins.
Flavin-containing oxygenases are generally comprised of a single polypeptide and frequently are
monooxygenases (Harayama et al. 1992).
As mentioned above, some oxygenases are comprised of a single polypeptide. Other oxygenases
require a short electron transport chain for their activity. Both monooxygenases and some dioxygenases
fall into this category. The electron transport chain is generally comprised of two redox centers: the first
containing a flavin and the second containing an iron-sulfur center. The redox centers are either in one
electron transport protein, or two separate proteins. The configuration of the redox centers varies with the
system. A schematic for electron transport systems is depicted in Figure 1-7. In general, electron
transport proteins acquire their electrons from NAD(P)H. This electron is then passed to the terminal
electron acceptor, the oxygenase, simultaneously activating the enzyme. For the rest of this chapter only
bacterial dioxygenases will be discussed.
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Figure 1-7: Electron Transport System of Oxygenases
Two electron transport systems are depicted that can either be for a monooxygenase or a
dioxygenase system. A) Single electron transport protein system, B) Multiple electron transport
protein system.
Bacterial Dioxygenases
There are two types of bacterial dioxygenases, ring-hydroxylating dioxygenases and ring-cleavage
dioxygenases (Butler and Mason 1997; Harayama et al. 1992; Mason and Cammack 1992). The ring-
hydroxylating dioxygenases incorporate two hydroxyl groups into the aromatic ring and require an electron
transport chain. The ring-cleavage dioxygenases likewise incorporate two hydroxyl groups into the
aromatic substrate, but they also catalyze ring cleavage and no electron transport chain is required. There
are two types of ring-cleavage dioxygenases, the intradiol (ortho) dioxygenases and the extradiol (meta)
dioxygenases. Intradiol dioxygenases cleave the aromatic ring between the two hydroxyl groups that were
added to the ring. Extradiol dioxygenases are cleaved outside of the hydroxyl groups (Figure 1-8). The
combined activities of the ring-hydroxylating dioxygenase and the ring-cleavage dioxygenase are a major
portion of the "upper pathway' of the aromatic compound catabolism by bacteria. These enzymes help
prepare the substrate for entry into lower pathway and central carbon metabolism. For a review of ring-
cleavage dioxygenases see the article by Harayama (Harayama et al. 1992). Only the ring-hydroxylating
dioxygenases will be discussed henceforth.
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Figure 1-8: Two types of Ring-cleavage Dioxygenase
There are two types of ring-cleavage dioxygenases, intradiol and extradiol. The distinction
between the two types is shown diagrammatically here. A) intradiol cleavage, B) extradiol
cleavage.
Ring-hydroxylating dioxygenases are tightly associated oligomers of a single subunit (an) or two
subunits (c,4r) that require an electron transport chain. All of the bacterial enzymes known to date are
non-heme enzymes that contain Rieske-type 2Fe-2S centers and one mononuclear iron cofactor that is
generally found in the a subunit (Ensley and Gibson 1983; Kauppi et al. 1998; Yamaguchi and Fujisawa
1982). Sometimes the iron-sulfur center is produced with components from both subunits (Mason and
Cammack 1992). The mononuclear iron binding site is also the active site of the enzyme.
There are three main classes of ring-hydroxylating dioxygenases (Batie et al. 1991; Butler and Mason
1997). This classification is based on the configuration of the electron transport chain and the
characteristics of the electron transport proteins. Figure 1-9 shows a schematic representation of the
different classes of dioxygenases with examples. Class I dioxygenase systems have two major
components: the flavoprotein reductase that contains both redox centers of the electron transport chain (a
flavin and a Fe-S center) and the dioxygenase. There are two subclasses, Class IA and Class lB. Class
IA has a flavoprotein reductase that has flavin mononucleotide (FMN) as the cofactor and an iron-sulfur
center. Class IB has flavin adenine dinucleotide (FAD) and an iron-sulfur center. Some examples of
Class I systems include the phthalate dioxygenase from Pseudomonas cepacia (Batie et al. 1987), 4-
sulphobenzoate 3,4-dioxygenase from Comamonas testosteroni (Locher et al. 1991), and 2-halobenzoate
1,2-dioxygenase from P. cepacia (Fetzner et al. 1992). Unlike Class I systems, Class I dioxygenase
systems are three component systems comprised of an oxygenase and two electron transport proteins.
Each of the electron transport proteins, the reductase component and the ferredoxin component, contain a
redox center. In all cases the reductase contains FAD as the cofactor and the ferredoxin contains the
iron-sulfur center. There are also two subclasses of Class 11, Class IIA and Class 11B, which are
differentiated by the type of ferredoxin. Class IIA dioxygenase systems have a ferredoxin with an iron-
sulfur center. Pyrazon dioxygenase from Pseudomonas is one such system (Sauber et al. 1977). Class
IIB systems, on the other hand, have a Rieske-type iron-sulfur center; Benzene dioxygenase (Geary et al.
1990) and biphenyl dioxygenase (Haddock and Gibson 1995) are known to be part of this class of
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enzymes. As with Class II systems, Class Ill dioxygenase systems have three components; the only one
known to date is the naphthalene dioxygenase system of Pseudomonas putida. This system is comprised
of the terminal oxygenase, a reductase flavoprotein that also contains an iron-sulfur center, and a
ferredoxin that contains a Rieske-type iron-sulfur center (Haigler and Gibson 1990a; Haigler and Gibson
1990b).
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Figure 1-9: Classes of Bacterial Dioxygenases
There are three classes of dioxygenases, both Classes I and II can be subdivided into two groups.
The type of electron transport chain and the characteristics of the electron transport proteins define
the classes. References: chlorobenzoate dioxygenase (Nakatsu et al. 1995; Nakatsu and Wyndham
1993), benzoate dioxygenase (Harayama and Rekik 1990; Neidle et al. 1991; Neidle et al. 1987;
Yamaguchi and Fujisawa 1982), dioxin/dibenzofuran dioxygenase (Armengaud et al. 1998;
Armengaud and Timmis 1997; Armengaud and Timmis 1998; Bunz and Cook 1993), toluene
dioxygenase (Subramanian et al. 1979; Subramanian et al. 1981; Subramanian et al. 1985; Zylstra
and Gibson 1989; Zylstra et al. 1988), and naphthalene dioxygenase (Ensley and Gibson 1983;
Haigler and Gibson 1990a; Haigler and Gibson 1990b; Kauppi et al. 1998).
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The dioxygenase enzyme mechanism and mode of electron transfer between components are
unknown. Recent work has begun to elucidate these mechanisms for some systems. One aspect of the
enzyme mechanism is substrate specificity and range; these attributes are highly variable among
dioxygenases. Consequently, there are as many different dioxygenases as there are different types of
aromatic hydrocarbons. In many cases substrate specificity has been shown, using subunit shuffling, to
be controlled by the large subunit (a subunit) of the dioxygenase (Furukawa et al. 1993; Hirose et al. 1994;
Suyama 1996; Tan and Cheong 1994). Further analysis of the large subunit and its role in substrate
specificity has determined that specific regions of the enzyme can be attributed to controlling substrate
selection. These regions are in various locations depending on the dioxygenase, but tend to cluster in the
C-terminal portion of the enzyme (Kimura et al. 1997; Mondello 1997; Parales et al. 1998). Furthermore,
specific amino acid substitutions have been made that confer new substrate specificity and range to the
altered enzyme (Beil et al. 1998; Kimura et al. 1997; Mondello 1997). Other researches, however, have
demonstrated that substrate specificity is determined, at least partially, by the small subunit (p subunit)
(Butler and Mason 1997; Hirose et al. 1994; Neidle et al. 1991). It seems that each dioxygenase is slightly
different in its method of determining substrate specificity.
Electron transfer to the dioxygenase activates the enzyme. A model for electron transfer has been
developed from analysis of the crystal structure of the naphthalene dioxygenase from Pseudomonas
putida (Kauppi et al. 1998). The enzyme is in an a3P 3 configuration, contains a Reiske 2Fe-2S center, and
a mononuclear iron. Analysis of the structure suggested that an electron is passed from the ferredoxin to
the Reiske 2Fe-2S center of the a subunit. This electron is then passed to the mononuclear iron located
in the neighboring a subunit, resulting in the activation of the dioxygenase. One particular amino acid,
Asp205, acts as an electron bridge between two neighboring a subunits. Replacement of this residue by
site directed mutagenesis results in a non-functional electron transport chain and disrupts naphthalene
dioxygenase activity (Parales et al. 1999). Site directed mutagenesis of the equivalent amino acid of the
toluene dioxygenase from P. putida also resulted in a non-functional dioxygenase (Jiang et al. 1996).
More research is needed to elucidate the enzyme and electron transfer mechanisms.
Bacterial Diol Dehydrogenases
Dehydrogenases are often categorized into three groups: the long-chain (Persson et al. 1991 a), the
medium-chain (Persson et al. 1994), and the short-chain dehydrogenases (Jornvall et al. 1995; Krozowski
1994). These classifications are based on the length of the polypeptide. Bacterial diol dehydrogenases
are part of the short chain dehydrogenase class. There is only one known exception to this, the benzene
dihydrodiol dehydrogenase (bedD) from Pseudomonas putida ML2 is a medium-chain dehydrogenase
(Fong et al. 1996). Other short-chain dehydrogenases include alcohol dehydrogenases and steroid
dehydrogenases, and the enzymes are approximately 250 amino acids in length. Unlike the medium
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chain varieties, the short chain dehydrogenases do not require metal ions as cofactors (Krozowski 1994).
When protein sequences of short chain dehydrogenases are aligned and compared, they contain several
strictly conserved residues that define the group including a coenzyme binding site (for NAD') and two
putative active site residues with one auxiliary residue (Persson et al. 1991 b).
Diol dehydrogenases play an important role in aromatic hydrocarbon metabolism. They are generally
responsible for the second step of the upper pathway. They prepare the compound for the second
oxygenation step by removing the hydrogen atoms from the ring making the compound more reactive and
susceptible to oxygen addition by a second dioxygenase. All bacterial diol dehydrogenases studied to
date require NAD' as a cofactor (Fong et al. 1996; Jeffrey et al. 1975; Khan et al. 1997; Patel and Gibson
1974). The substrate specificities of these enzymes are not well characterized. However, many have
been shown to be able to utilize a variety of diol substrates to varying degrees (Rogers and Gibson 1977;
Werlen et al. 1996; Keat and Hopper 1978; Patel and Gibson 1974; Sylvestre et al. 1996). A few
dehydrogenases have been shown to be stereoselective including the cis-biphenyl dihydrodiol
dehydrogenase from Sphingomonas yanoikuyae B1 (Eaton et al. 1996) and the naphthalene dihydrodiol
dehydrogenase from Pseudomonas putida (Jeffrey et al. 1975).
Genetics of Aromatic Compound Degradation
There are as many different types of aromatic hydrocarbons as there are different types of
dioxygenases. These enzymes have been named unsystematically based on the substrate used to
identify the dioxygenase. Upon further analysis of these enzymes it has been found that the substrate
range and specificity of these enzymes are highly variable. For example, the naphthalene dioxygenase
system from P. putida has been shown to have a long and diverse list of possible substrates (Resnick et
al. 1996). Consequently the naming of genes for dioxygenase systems is not always reflective of the
enzyme's function.
The process of identifying genes for aromatic hydrocarbon metabolism begins with the identification of
a strain capable of consuming such compounds as a carbon source. Strains capable of utilizing aromatic
compounds as carbon sources have been isolated using classical enrichment protocols. Researchers
have used various aromatic compounds, including toluene, naphthalene, benzene, and isopropyl benzene
among others, as a carbon source to isolate bacteria. The genes responsible for the metabolism of these
compounds have been isolated in a variety of ways. In earlier studies aromatic metabolizing
Pseudomonads strains were identified that could utilize naphthalene, toluene, or xylene and then
subjected to transposon mutagenesis in order to map the genes. This method was heavily utilized in the
analysis of the TOL (toluene utilizing) plasmids and NAH (naphthalene utilizing) plasmid from
Pseudomonas (Lehrbach et al. 1983; Nakazawa et al. 1980; Yen and Gunsalus 1982). Many of the genes
encoding these functions have been cloned using a variety of methods. For example, some of the TOL
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plasmid genes from P. putida (xyICMABN) were cloned by expressing the genes in a heterologous host
(Escherichia coi) and examining the products formed during aromatic substrate utilization by high
pressure liquid chromatography (Harayama et al. 1989). The nah genes encoding the utilization of
naphthalene from the NAH7 plasmid in Pseudomonas putida were cloned in a similar manner (Schell
1983).
Some aromatic degradation operons have been cloned by using an enzyme specific functional assay
in a heterologous host. There are two documented colorimetric functional assays that have been used
extensively to identify genes. One method identifies ring-hydroxylating dioxygenases, the other identifies
ring-cleavage dioxygenases. The identification of ring-hydroxylating dioxygenases takes advantage of the
observation that these enzymes have been shown to convert indole to indigo (Ensley et al. 1983);
however, in some cases expression of the required enzyme can be host dependent (Kim and Zylstra
1995). For this assay, called the indigo formation assay, indole is added as the substrate in the vapor
phase to grown cells. The presence of ring-hydroxylating activity is detected by a color change in the cells
ranging from brown to green to blue to purple. This assay has been used to isolate dioxygenase genes
and related components from a variety of systems. For example, the isopropyl benzene (ipb) genes from
Rhodococcus erythropolis (Kesseler et al. 1996), the xylene/toluene (xyl) genes from Pseudomonas
putida mt-2 (Keil et al. 1987), a polycyclic aromatic hydrocarbon dioxygenase that can oxygenate
naphthalene, phenanthrene, and anthracene from Pseudomonas fluorescens (Foght and Westlake 1996),
a 2,4-Dinitrotoluene (DNT) dioxygenase from Burkholderia (Suen et al. 1996), and
phenanthrene/naphthalene dioxygenase from Comamonas testosteroni (Goyal and Zylstra 1996) were all
isolated using the indigo formation assay.
The second common colorimetric functional assay has been used to identify dioxygenases of the ring-
cleavage variety rather than ring-hydroxylating dioxygenases. This assay uses a ring-cleavage substrate
that when cleaved produces a colored product. When this substrate is sprayed onto grown colonies that
are expressing a ring-cleavage dioxygenase, often the colonies will turn yellow/brown due to the
conversion of the compound to a colored product. For example, toluene is converted into 2-
hydroxymuconic semialdehyde, which is yellow in color, by the product of the xyIE gene from P. putida.
The xyIE gene was cloned using this colorimetric assay from a genomic library expressed in a
heterologous host (Franklin et al. 1981). This method has also been used to clone genes responsible for
toluene and xylene metabolism from Pseudomonas stutzeri OXI (Bertoni et al. 1996). Poly-aromatic
hydrocarbon ring-cleavage genes have been isolated in a similar fashion. For example, a 3-
phenylcatechol dioxygenase from P. putida was cloned by screening a cosmid library for clones that
turned yellow in the presence of 2,3-dihydroxybiphenyl due to the formation of 2-hydroxy-6-oxo-6-
phenylhexa-2,4-dienoic acid (Khan et al. 1988). Three different 2,3-dihydroxybiphenyl dioxygenases were
identified from Rhodococcus globerulus P6 using the same substrate (Asturias and Timmis 1993).
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Classical genetic and molecular biology methods have also been used to clone aromatic hydrocarbon
degradation operons. The generation of mutants (both chemical and transposon insertion) unable of
utilizing an aromatic carbon source and followed by complementation of those mutants with clones from
an expression library or cosmid library is a very common methodology. For example, two separate
research groups created mutants of the Rhodococcus erythropolis IGTS8 that were unable to utilize sulfur
using chemical or UV mutagenesis and isolated the sox/dsz genes by complementation (Denome 1993;
Piddington et al. 1995). Other genes for aromatic hydrocarbon degradation have been isolated in a similar
way including the pca genes encoding the meta-cleavage pathway of protocatechuate in Acinetobacter
calcoaceticus (Doten et al. 1987), and the ben genes for the benzene lower pathway (also called the
benzoate pathway) from P. putida (Jeffrey et al. 1992). Furthermore, the availability of sequenced genes
has made it possible to use molecular biological techniques such as degenerate polymerase chain
reaction (PCR) and other methods based on homology to clone aromatic degradation genes (Gennaro et
al. 1997; Hedlund et al. 1999). Sometimes these methods are coupled with prior enzyme purification and
amino acid sequencing to provide the necessary sequence information (Eulberg et al. 1997; Strachan et
al. 1998).
A novel screening method for mutants defective in toluene degradation developed by Finette and
colleagues (Finette et al. 1984) combines a colorimetric assay with classic complementation. The
colorimetric assay is based on the redox reactions of the electron transport system and the final electron
acceptor, the ring-hydroxylating dioxygenase. Chemically mutagenized cells were screened for strains
defective in toluene utilization by the addition of the redox dyes nitro blue tetrazolium (NBT) and 2,3,5-
triphenyl-2H-tetrazloium chloride (TTC) in minimal medium. These dyes are different colors depending on
their redox state. Wildtype strains will be red due to the reduction of the TTC. Toluene dioxygenase
mutants (including the electron transport genes) range from white to light blue depending on the mutation
due to the NBT. The tod genes for the canonical toluene dioxygenase system in P. putida F1 were cloned
by complementation using this mutagenesis and screening method (Zylstra et al. 1988).
The subsequent sequencing and analysis of the identified genes has led to some generalizations
about the gene organization of aromatic degradation/metabolism systems. There are two overlying
themes for the gene organization for operons carrying genes for aromatic compound degradation. Either
the genes of the upper and lower pathway appear to be all in one single operon (Zylstra and Gibson
1989), or there are two separate operons that encode the upper and lower pathways separately (Favaro et
al. 1996; Franklin et al. 1981; Harayama et al. 1989; Kukor and Olsen 1991; Osborne et al. 1988). Upon
closer inspection of the individual operon components, the lower pathways that have been identified are
remarkably similar in their gene order (Williams and Sayers 1994). The upper pathways, however, are
more variable in their gene order. However, it seems that often the genes are organized in the same
order that the enzymes they encode are needed in the pathway. Generally, the components of the
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dioxygenase system are clustered together first. They are followed by the genes encoding the diol
dehydrogenase and the ring-cleavage dioxygenase (sometimes called the catechol dioxygenase). A
generalized schematic of the gene organization of the upper pathway for a single ring aromatic compound
is shown in Figure 1-10. These operons can be found on the chromosome (Kiyohara et al. 1994; Polissi
et al. 1990; Wright and Olsen 1994), on circular plasmids (Assinder and Williams 1990; Fuenmayor et al.
1998; Williams and Worsey 1976), and linear plasmids (Dabrock et al. 1994). In some cases the plasmid
encoded operons are also part of a transposon, some of which are known to actively transpose (Tsuda
and lino 1987) and others that do not (Tsuda and lino 1990).
doxA1.,4  doxB doxC
II
Figure 1-10: General Operon Structure for Upper Pathway Genes
Genes for the upper pathways of aromatic catabolism systems are often organized in a similar
manner in different organisms. The diagram shows a general pattern seen in these upper pathway
operons.
Actinomycetes
As mentioned above, there is a wide range of organisms capable of utilizing aromatic compounds as
carbon sources and in biocatalysis. One such group of resilient bacteria is the actinomycetes.
Actinomycetes are Gram-positive, and can be aerobes, anaerobes or facultative anaerobes. They are
commonly found in the soil, fresh water, and extreme environments. Actinomycetes are also known to be
plant pathogens (EI-Raheem et al. 1995; Takeuchi et al. 1996) and human pathogens such as
Corynebacterium diphtheriae (diphtheria), Mycobacterium tuberculosis (tuberculosis), and Mycobacterium
leprae (leprosy). In biotechnology, actinomycetes are best known for their ability to produce antibiotics
(Streptomcyes) (Alderson et al. 1993; Baltz 1998), vitamins (Plaut et al. 1974), and enzymes used to
produce precursors of pharmaceutical agents (Goodfellow et al. 1984). For example, a precursor to
Throbaxane A2 Antagonist, a vasoconstrictor, is produced using enzymes from Rhodococcus and
Nocardia globerula (Patel 1997). Actinomycetes are also used to transform xenobiotics, such as aromatic
hydrocarbons, steroids, and pesticides (Peczynska-Czoch and Mordarski 1984).
Actinomycetes are generally described as bacteria with elongated cells or filaments that have the
ability to form branching hyphae at some stage of development (Goodfellow et al. 1984). Actinomycetes
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have cell walls rich in lipids and a high G+C content (generally > 55%)(Goodfellow and Cross 1984;
Williams et al. 1984). The colony morphology can be quite diverse; they can be round, rough, smooth, or
mucoidal. Furthermore, the morphology can change over the life cycle of the cells. There are two broad
morphological groups of actinomycetes, the sporo- and the nocardioform- actinomycetes. These groups
are distinguishable, as their names imply, by the formation of spores by the former and hyphae by the
latter. The sporo-actinomycetes comprise the majority of the different species in this group of bacteria.
Nocardioform-actinomycetes can also be distinguished from other actinomycetes by the presence of
mycolic acids in their cell wall and they tend to have a G+C content around 62% (Williams et al. 1984).
Included in the nocardioform actinomycetes are the Corynebacterium, Mycobacterium, Nocardia, and
Rhodococcus.
Rhodococcus
Rhodococci are part of the nocardioform-actinomycetes, many species were previously categorized
as Nocardia. They are very diverse morphologically and often colored, as their name implies, ranging
from buff to orange to red. Changes in morphology of individual cells during the life cycle can cause
dramatic effects on the colony morphology (Goodfellow and Cross 1984). Species of Rhodococci are
aerobic, non-motile, lysozyme sensitive, and may be acid fast. The genetics and molecular biology of
Rhodococcus species is not well characterized. Some genetic analysis was conducted with this genus in
the latel 960's and early 70's, including preliminary genetic mapping via conjugation studies of a R.
erythropolis strain. However, much of this work was contradictory and therefore inconclusive (Brownell
and Denniston 1984). Over the last five years there has been a renewed interest in the genus for their
ability to tolerate solvents and catalyze stereospecific enzymatic reactions. Consequently some genetic
tools have been developed including plasmids and selectable markers (Dabbs 1990; Quan and Dabbs
1993; Vogt Singer and Finnerty 1988), and transformation protocols (Desomer et al. 1990) to name a few.
However, due to the diverse nature of the genus not all of the tools are transferable from one strain to
another.
Rhodococci have been found to occupy a variety of environmental niches. There are some species
capable of residing in the guts of blood-sucking arthropods (Goodfellow and Cross 1984). Others are
pathogenic including R. equi, which can be an equine and human pathogen (Prescott 1991), and R.
fascians which is a plant pathogen (Crespi et al. 1994). As mentioned previously, many isolates of
Rhodococcus are capable of living in soils contaminated with aromatic compounds (Bell et al. 1998;
Kulakova et al. 1996; Warhurst et al. 1994; Warhurst and Fewson 1994). Some Rhodococci have been
used in bioconversions. For example, Rhodococcus can the desulfurize fuel components (Gray et al.
1996), and a hydrolase from Rhodococcus can assist in the synthesis of a P-blocker (Zaks and Dodds
1997). The ability of Rhodococcus species to utilize aromatic hydrocarbons and carry out bioconverions
makes the species a resource for the bioconversion of indene.
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Rhodococcus Strain 124
Rhodococcus strain 124 was isolated as a strain capable of utilizing naphthalene as a sole carbon
source from a toluene contaminated aquifer (Buckland et al. 1999; Chartrain et al. 1998). It is a strict
aerobe that forms pleomorphic filaments. The strain is also capable of utilizing toluene as a carbon
source, but not xylene, biphenyl, or indene. The phylogeny of Rhodococcus strain 124 was determined by
DNA fingerprint analysis of the tRNA genes and found to cluster with other strains of Rhodococcus that
are able to oxidize alkylbenzenes (Raymond and Jamison 1968a; Raymond and Jamison 1968b) (Figure
1).
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Figure 1-11: Phylogenetic Analysis of Rhodococcus strain 124
Figure redrawn from (Chartrain et al. 1998). Rhodococcus strain 124 is also known as MB 7209.
Due to its ability to utilize naphthalene and toluene as carbon sources Rhodococcus strain 124 was a
candidate strain for use in a bioconversion to produce a precursor for the HIV-1 protease inhibitor
CrixivanTM as discussed above. Presumably by using the enzymes that allow the utilization of naphthalene
and toluene as carbon sources, Rhodococcus strain 124 is capable of converting indene to three
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enantiomers of indandiol, 1 -indenol, 1 -indanone, and keto-OH-indan in the presence of a carbon source
(Buckland et al. 1999; Chartrain et al. 1998). The production of these compounds was confirmed by NMR
analysis (Chartrain et al. 1998). Even though indene is not a carbon source for this strain it can
adequately induce the dioxygenase system as evidenced by indene bioconversion. It has been
demonstrated in Pseudomonas that aromatic degradation systems often need to be induced (Fuenmayor
et al. 1998; Mermod et al. 1987). Indene, however, it not likely an optimal inducer for the system since it is
not a natural substrate. As a result, Chartrain and colleagues (1998) conducted induction studies with
naphthalene and toluene and examined the indene bioconversion product profile. When naphthalene was
used to induce the system, cis-(1 R,2S)-indandiol and trans-(1 R,2R)-indandiol were produced immediately.
When toluene was used as the inducer, cis-(1S,2R)-indandiol was the first enantiomer of indandiol
produced (Chartrain et al. 1998).
From the bioconversion studies, the induction studies, and the general pathways already established
for aromatic hydrocarbon degradation (see above) a pathway for indene bioconversion was proposed for
Rhodococcus strain 124 (Figure 1-12) (Buckland et al. 1999; Chartrain et al. 1998). In the proposed
pathway there may be three different enzyme systems responsible for converting indene into the various
1,2-indandiols in a stereospecific manner. The Rhodococcus 124 strain may possess a naphthalene-
inducible dioxygenase, a toluene-inducible dioxygenase, and a naphthalene-inducible monooxygenase
which all contribute to the oxygenation of indene. The presence of multiple oxygenase enzymes in an
organism capable of utilizing a common substrate is not uncommon (Asturias and Timmis 1993; Kosono
et al. 1997; Maeda et al. 1995). Additionally, dioxygenases have been found to stereospecifically
hydroxylate their substrates (Boyd et al. 1989; Hamberg et al. 1994; Lee and Gibson 1996; Lee et al.
1997; Resnick et al. 1994). Furthermore, oxygenases have been identified that can stereospecifically
oxygenate indene (Allen et al. 1997; Gibson et al. 1995; Wackett et al. 1988). A single enzyme complex
may be responsible for both the naphthalene-inducible mono- and dioxygenase activities. Earlier work
with Pseudomonas has demonstrated that naphthalene dioxygenases can act both as dioxygenases and
monooxygenases (Gibson et al. 1995; Spain et al. 1989).
As discussed above, oxygenation reactions are generally followed by a dehydrogenation reaction in
aromatic hydrocarbon degradation pathways. In Rhodococcus strain 124, each of the indandiols produced
from indene may be oxidized to keto-OH-indan. These reactions may be carried out by a single
dehydrogenase or by separate dehydrogenases specific to each pathway. Overall, the proposed indene
bioconversion pathway of Rhodococcus strain 124 has multiple oxygenase systems. Each branch of the
pathway resembles a portion of the "upper pathway" seen in other aromatic compound degrading bacteria
including Rhodococcus and Pseudomonas.
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Figurel-12: Proposed Indene Bioconversion pathway from Rhodococcus strain 124
This pathway figure was adapted from (Buckland et al. 1999; Chartrain et al. 1998). Indenediol is
a putative intermediate not detected by HPLC.
As discussed above, either trans-(1R,2R)-indandiol or cis-(1S,2R)-indandiol can be used as a
precursor for the HIV protease inhibitor indinavir sulfate (Buckland et al. 1999). We are interested in
analyzing genetically and biochemically the oxygenation and dehydrogenation steps of indene
bioconversion in Rhodococcus strain 124. This analysis will provide more insight into the indene
bioconversion network to facilitate the development of rational methods to control the production of
indandiol in this strain and provide a fundamental understanding of bacterial aromatic compound
degradation. More specifically, in this work the. identification of a ring-hydroxylating dioxygenase and a diol
dehydrogenase from Rhodococcus strain 124 are identified. The screening, cloning and initial
characterization of the genes are described in chapter two. The characterization of the diol
dehydrogenase both genetically and biochemically is described in chapter three.
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Chapter Two: Isolation and Characterization of Indene Bioconversion
Genes from Rhodococcus strain 124
Abstract
Rhodococcus strain 124 is able to convert indene into indandiol via the actions of at least two
dioxygenase systems and a putative monooxygenase system. We have identified a cosmid clone from
124 genomic DNA that is able to confer the ability to convert indene to indandiol upon Rhodococcus
erythropolis SQ1, a strain that normally can not convert or metabolize indene. HPLC analysis revealed
that the transformed SQ1 strain produces cis-(l R, 2S)-indandiol suggesting that the cosmid clone
encodes a naphthalene-type dioxygenase. DNA sequence analysis of a portion of this clone confirmed
the presence of genes for the dioxygenase as well as genes encoding a dehydrogenase and putative
aldolase. These genes will be useful for manipulating indene bioconversion in Rhodococcus strain 124.
Introduction
The ability of many bacteria to metabolize aromatic compounds makes them useful tools to
synthesize enantiopure precursors of biologically active products (Collins et al. 1997). Common
precursors are diols (Carless 1992) that can be produced in oxygenation reaction carried out by
multicomponent dioxygenase systems (Mason and Cammack 1992), or produced by successive
monooxygenation reactions. Dioxygenation is the initial reaction in the breakdown of many aromatic
compounds and is generally followed by a dehydrogenation reaction (Grund et al. 1995; Zylstra 1994).
There are many examples of such aromatic degradation pathways in both Gram negative and Gram
positive bacteria including Pseudomonas and Rhodococcus (Allen et al. 1997; Masai et al. 1995; Zylstra et
al. 1989).
Rhodococcus strain 124, isolated from soil contaminated with aromatic compounds, is capable of
metabolizing naphthalene and toluene as sole carbon sources (Chartrain et al. 1998). Although this strain
can not use indene as a sole carbon source, it can oxygenate indene in the presence of a carbon source.
It is hypothesized that the same oxygenase systems that allow catabolism of naphthalene and toluene
allow Rhodococcus strain 124 to oxygenate indene. Indene is converted to a variety of indandiols, two of
which can be utilized as precursors in the synthesis of the HIV protease inhibitor indinavir sulfate
(Buckland et al. 1999). A pathway for indene bioconversion in this strain of Rhodococcus has been
proposed based on the analysis of indene breakdown in the presence and absence of naphthalene and
toluene as inducers (Figure 2-1)(Buckland et al. 1999; Chartrain et al. 1998).
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Figure 2-1: Proposed Indene Bioconversion Pathway in Rhodococcus 124
This pathway is adapted from Buckland et al. (1999) and Chatrain et al. (1998). The pathway was
developed based on bioconversion analysis and induction studies. All products are detectable by
HPLC except for indenediol. Indenediol is a proposed intermediate of the dehydrogenation
reaction that isomerizes to keto-OH-indan.
Initial analysis of the system suggests that there are three reactions, possibly carried out by three
different enzyme systems (or complexes), by which indene can be converted to a 1,2-indandiol. The
presence in a given organism of multiple oxygenase enzymes capable of utilizing a common substrate is
not uncommon (Asturias and Timmis 1993; Kosono et al. 1997). Chartrain and colleagues (Chartrain et
al. 1998) have proposed that the bioconversion of indene in the 124 strain is conducted by a naphthalene-
inducible dioxygenase, a toluene-inducible dioxygenase, and a naphthalene-inducible monooxygenase.
An indene derived compound with the same retention time as chemically synthesized indan oxide is
proposed to be produced in a monooxygenation reaction. The structural identity of this compound has not
yet been determined. It is possible that the naphthalene-inducible monooxygenase activity is a second
reaction of the proposed naphthalene dioxygenase since both reactions are inducible by naphthalene.
Naphthalene dioxygenases have been characterized from Pseudomonas that can act both as
dioxygenases and monooxygenases (Gibson et al. 1995). Interestingly, each of the proposed oxygenation
reactions in Rhodococcus strain 124 seems to produce a specific indandiol stereoisomer suggesting
discrete enzyme mechanisms. Other oxygenases have been found to act upon indene in a stereospecific
manner (Gibson et al. 1995; Wackett et al. 1988).
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In the proposed pathway shown in Figure 2-1, each of the oxygenation reactions is followed by a
dehydrogenation reaction. These reactions may be carried out by a single dehydrogenase or by separate
dehydrogenases whose expression and substrate specificity correlate with their respective dioxygenase or
monooxygenase. We are interested in analyzing at the genetic level the oxygenation and
dehydrogenation steps of this indene bioconversion in order to better understand and control the
production of indandiol in this strain.
This chapter describes the initial genetic analyses of the Rhodococcus 124 genome and the
Rhodococcus 124 indene bioconversion pathway. Using a functional screen for dioxygenase activity, we
identify genes encoding the large and small subunit of a naphthalene-type dioxygenase, a dehydrogenase,
and a putative aldolase. We demonstrate that the dioxygenase is capable of oxygenating indene. The
implications of the findings on the proposed model for indene bioconversion in this strain and the
relationship of these genes to previously identified dioxygenase genes are discussed.
Materials and Methods
Reagents
All strains and plasmids used in this study are listed in Table 2-1. All chemicals were reagent grade
and purchased from Sigma (St. Louis, MO) or Aldrich Chemical Co (Milwaukee, WI) unless otherwise
noted. All media components were purchased from Difco (Detroit, MI).
Table 2-1: Strains and Plasmids
Strains Description Reference
Rhodococcus 124 Converts indene to indandiol, orange colonies Buckland et al, 1998
Rhodococcus SQI Easily transformable isolate of R. erythroplis Quan and Dabbs, 1993
Escherichia coli JM109 endA 1, recA 1, gyrA96, thi, hsdR 17, (rk-, mk+), Yanisch-Peron, C., Viera,
relAl, supE44, X-, A(lac-proAB), [F', J., and Messing, J., 1985
traID36, proAB, lacPZAM15]
Plasmids
SuperCOS AmpR, KanR, colEl ori, COS sites Stratagene
pEP2 KanR, NG2 ori Zhang, 1994
pRhodoCOS KanR, NG2 ori, COS sites This study
pR4 KanR, NG2 ori, 124 genomic cosmid clone This study
pR4-10 KanR, NG2 ori, Sau3a pR4 subclone This study
Pulse Field Gel (PFG) Analysis
Pulse field gel analysis was carried out using a protocol modified from Lai and Birren (Lai and Birren
1990). Genomic DNA from Rhodococcus 124 was prepared for PFG analysis from cultures grown in LB
medium to an OD 600 of 0.8 -1.0 and treated with 0.2 mg/ml chloramphenicol and 0.01% isoniazid for two
42
hours. The cells and DNA were then treated as described (Lai and Birren 1990) except that the agitation
step during 24-hour lysis was omitted. InCert@ agarose (FMC, Philadelphia, PA) was used to embed the
cells. To prepare for enzyme digestion, gel slices were equilibrated in TEN Buffer (10 mM Tris pH 8.0, 1
mM EDTA, 50 mM NaCI) overnight at room temperature. Individual gel slices were then treated with 10
mg of Pefabloc SC (Boehringer Mannheim, Indianapolis, IN) in 1 ml of TE pH 8.0 for 2 hours at 370C. Gel
slices were subsequently equilibrated in 45 ml of TEN Buffer for one hour to remove excess protease
inhibitor. Gel slices were digested with Asel and Sspl (New England Biolabs, Beverly, MA) in their
appropriate buffers and were incubated at 40C overnight followed by a 6-8 hour incubation at 370C.
The digested samples were analyzed in 1% agarose (Gibco BRL, Grand Island, NY) 0.5X TBE gels
run in a BioRad Chef-DR 11 Pulse Field Gel Apparatus at 6 V/cm at 140C for 16-19 hours at a ramp time of
15-75 seconds for Asel and 1-40 seconds for Sspl. Different ramp times were used to increase resolution
over certain size ranges. For 20-350 kb fragments a ramp time of 1-25 seconds was used. A ramp time
of 1-40 seconds resolved 20-450 kb fragments. Fragments of 250-850 kb were resolved at 15-75
seconds and 450-750 kb fragments by 30-60 seconds ramp time. The Lambda DNA PFG Ladder used as
a molecular weight marker was obtained from New England Biolabs (Beverly, MA).
DNA Manipulation and Plasmid Construction
Restriction enzymes were purchased from New England Biolabs (Beverly, MA) and used according to
the manufacturer's recommendations. Plasmid DNA was prepared using the Wizard Maxiprep Kit and the
Wizard Miniprep Kit from Promega (Madison, WI), or boiling lysis miniprep (Sambrook et al. 1989).
To construct the cosmid vector pRhodoCOS, pEP2 (Zhang et al. 1994) was partially digested with
HinCIl, then digested with BamHI and treated with Shrimp Alkaline Phosphatase (Boehringer Mannheim,
Indianapolis, IN). The 3.1 kb HinCll-BamHl fragment of pEP2 was ligated to the 4.2 kb Bgill-Scal
fragment of SuperCOS (Stratagene, La Jolla, CA) to create pRhodoCOS. E. co/iJM109 were transformed
by electroporation (Sambrook et al. 1989) and plated on LB plates containing 100 pg/ml kanamycin. The
pR4 subclones were made by a Sau3Al partial digest of 1.5 pg of pR4 DNA using 0.4 units of enzyme for
1 minute at 370C followed by heat inactivation at 650C for 20 minutes, followed by re-ligation. Subclones
were analyzed be restriction enzyme digest with the following enzymes PsI, EcoRl, NoI, Clal, Pvull, and
Ncol.
Preparation of Rhodococcus Genomic DNA and Library
Genomic DNA was prepared from Rhodococcus as follows. A 200 ml LB culture was grown to
saturation at 300C. Cells were harvested by centrifugation for 10 min at 4000 x g; the supernatant was
removed and the pellet was frozen at -20*C for 30-60 minutes. The pellet was resuspended in 5 ml TE
with 20 mg lysozyme and 200 gg mutanolysin, and incubated for one hour at 370C with shaking. One ml
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of 0.5 M EDTA, 1 ml of 10% SDS, and 1 ml of 5M NaCI were added, and the cell suspension was mixed
gently and incubated on ice for 10 min. The cell suspension was then treated with 2 mg of proteinase K
for one hour at 370C. Proteinase K treatment was followed by the addition of 3.77 g sodium perchlorate to
the cell suspension which was mixed gently and incubated at room temperature with gentle agitation for
30 minutes. The cell suspension was extracted with one volume of phenol:chloroform:isoamyl alcohol
(25:24:1), vortexed and centrifuged for 20 min at 4000 x g . The aqueous phase was extracted with 0.5
volumes of chloroform:isoamyl alcohol (24:1), vortexed and recentrifuged. To the aqueous phase two
volumes ice cold 100% ethanol was added. The DNA was spooled onto a glass rod and resuspended in 5
ml TE. Next 50 pl RNase (Boehringer Mannheim, Indianapolis) was added and the sample was incubated
at 370C for 30 min. The solution was extracted with one volume of phenol:chloroform:isoamyl alcohol
(25:24:1), vortexed and centrifuged for 20 minutes at 4000 x g. The aqueous phase was extracted with
0.5 volumes of chloroform:isoamyl alcohol (24:1), vortexed and recentrifuged. The aqueous phase was
ethanol precipitated with two volumes of cold ethanol and 0.1 vol. of 3M sodium acetate, and the DNA was
spooled on a glass rod and washed in 70% ethanol for 3 minutes. The DNA was air dried for 5-10
minutes and resuspended in TE. The 124 genomic DNA was quantitated and subjected to partial digest
with 0.4 units of Sau3Al for 1 minute at 370C and the restriction enzyme was heat inactivated at 650C for
20 minutes.
The cosmid library of Rhodococcus 124 was made using pRhodoCOS following the Stratagene (La
Jolla, CA) protocol provided with the SuperCOS vector kit and Gigapack Ill XL packaging extract. JM109
E. coli was used as the host strain for the cosmids (Yanisch-Perron et al. 1985). The resulting library
contains 286 cosmid clones.
Screen for Dioxygenase Activity In Vivo
The cosmid clones in JM109 E. co/i cells were grown on LB plates containing 100 pg/ml kanamycin
at room temperature for three to four days and screened for blue color development. In R. erythropolis
SQ1, blue color development was assayed by first growing colonies at 300C. After the Rhodococcus
colonies reached 2-3 mm in diameter, filter paper containing 600 jla 3% indole (w/v in DMF) was placed in
the lid of petri dish and plate was sealed with parafilm. Plates were kept at room temperature for 24-48
hours to allow for blue color formation. The dimethylformamide (DMF) was purchased from Fisher
Scientific (Fair Lawn, NJ).
Transformation of R. erythropolis SQ1
Competent Rhodococcus cells were prepared as follows. A 100 ml culture of R. erythropolis SQ1 in
MB (5g/L yeast extract, 15 g/L Bacto-Tryptone, 5 g/L Bacto-soytone, 5 g/L NaCI), 1.5% glycine, 1.8%
sucrose, 0.01% isoniazid was grown at 300C to an OD6 00 of -1.6-1.8 (Hewlett Packard Diode Array
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Spectrophotometer 8452A). The culture was treated 1 pl of 100 mg/ml ampicillin and incubated at 300C
for one hour. The cells were harvested by centrifugation at 4000 x g for 10 minutes and washed twice
with 30 ml cold EPB1 (20 mM Hepes pH 7.2, 5% glycerol). The washed cells were resuspended in 2 ml
cold EPB2 (5 mM Hepes pH 7.2, 15% glycerol). Competent cells were stored at -80*C.
Electroporation using a BioRad Gene Pulser set to 2.50 kV, 400 Ohms, 25 Fd was used to transform
70 gl competent cells with -1 gg DNA. Immediately after electroporation the cells were transferred to a
microfuge tube and 400 pl of Recovery Broth (80 g/L Brain Heart Infusion mixed with equal volume of
Solution 2 (80 g/L Sorbitol, 20 g/L Sucrose)) was added and incubated at 300C for one hour without
agitation. The transformation was plated on LB plates supplemented with 200 gg/ml kanamycin and
grown at 300C for 3-5 days.
Plasmid Miniprep from Rhodococcus
This protocol is based on a protocol from Vogt Singer and Finnerty (Vogt Singer and Finnerty 1988)
with many modifications. LB cultures of Rhodococcus were grown to saturation at 300C (approximately
two days). A 1.5 ml sample was pelleted in a microfuge tube and the supernatant was discarded. The
pellet was resuspended in 400 pl TENS (50 mM Tris HCI pH8.0, 10 mM EDTA, 50 mM NaCl, 20%
sucrose) with 5 mg/ml fresh lysozyme and incubated at 370C for 30 minutes. Then 185 pl 1 0%SDS and
30 pI of 1 M Tris pH12.6 (adjusted with NaOH) was added. The suspension was incubated at 550C for 30
minutes. 300 pl of Potassium acetate (3M potassium, 5 m acetate: 29.44 g potassium acetate, water to
88.5 ml, 11.5 ml glacial acetic acid) was added and the solution was incubated on ice for 5 minutes. The
mixture was centrifuged for 20 minutes and the supernatant was transferred to a new tube. The DNA was
precipitated with 0.6 volumes (450 pl) of isopropanol and centrifuged for 20 minutes. The pellet was
washed in 70% ethanol and resuspended in 30 pl TE (10 mM Tris-HCI pH8.0, 1 mM EDTA).
Indene Bioconversion
Cultures containing 25 ml of LB, 5 ml of silicon oil, 150 pl indene, and 150 pig/mI kanamycin (if
appropriate) were grown at 300C for 4 days for end point bioconversion data. 1.0 ml samples of media
were extracted with 6 ml of HPLC grade isopropanol (Mallinckrodt, Paris, KY) and 3 ml of milliQ water.
Samples were vortexed and cleared of cells in a 5 min centrifugation at 4000 x g. The samples were then
filtered through a 0.22 pm PVDF syringe filter (Alltech, Deerfield, IL) and 20 pl of the filtrate was injected
onto a Zorbax Rx-C8 4.6x250 mm HPLC column on a Rainin Dynamax HPLC System. The HPLC
protocol was followed as previously described (Chartrain et al. 1998). The indene, the silicon oil, and the
HPLC standards cis-indandiol, trans-indandiol, 1-indenol, 1-indanone, and keto-hydroxy-indan were gifts
from M. Chartrain (Merck Research Laboratories, Rahway, NJ). HPLC grade acetonitrile was purchased
from Mallinckrodt (Paris, KY). Chirality of the cis-indandiol was determined by Chiral HPLC analysis as
previously described (Chartrain et al. 1998).
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DNA Sequencing and Analysis
Sequencing of pR4 was performed at the MIT Biopolymers Facility using an ABI cycle sequencer by
primer walking. Primers were synthesized by Gibco/BRL Life Technologies (Grand Island, NY). pR4-10
was sequenced by primer walking by Lark Technologies Inc. (Houston, TX) using Big DyeTM Terminator
Cycle Sequencing Reactions (PE-ABD). Reactions were analyzed on a 5.75% Long RangerTM gels by an
ABI 373A-S or on 5.0% Long RangerTM gels by an ABI 377 automated sequencer. Approximately 43% of
the sequence data are from both strands, 31% of the data are from multiple fragments in the same
direction, and 26% is from single fragments.
All sequence data were analyzed using GenBank, EMBL, Swissprot databases, the BLASTN,
BLASTP, and BLASTX (Altschul et al. 1990; Gish and State 1993) programs via the National Center for
Biotechnology Information server, and PROSITE protein database (Bairoch 1992) via the ExPASy web
site (http://expasy.hcuqe.ch/sprot/prosite.htmi). Alignments, percent similarity, and phylogenetic analysis
was carried using the Lasergene program (DNA star, Madison, WI) via a CLUSTAL alignment using a
PAM250 residue weight table.
GenBank Accession Number
The GenBank number assigned to the DNA sequence data presented in this chapter is AF1 21905.
Results
Genome Size Analysis and Genomic Cosmid Library Construction
Rhodococcus strain 124 was previously isolated from soil contaminated with aromatic compounds
(Buckland et al. 1999; Chartrain et al. 1998). Since this strain is not well characterized and nothing was
known about the genomic content of the strain, we determined the approximate size of the genome using
pulse-field gel analysis in order to facilitate further genetic analysis of the strain. This information is
particularly pertinent to the construction of any genomic library. Given the fact that Rhodococci and
related species are G+C rich (63-72%) (Williams et al. 1984), the enzymes Asel (ATVTAAT) and Sspl
(AATVATT) were used in the PFG gel analysis because they are specific for AT rich regions and would
likely digest the genomic DNA infrequently producing a reasonable number of fragments to quantitate.
Figure 2-2 shows a representational pulse-field gel analysis of Rhodococcus 124 genomic DNA. By
varying the ramp times we were able to increase the resolution over several size ranges to get a more
accurate representation of the genomic content. The results from these analyses are shown in Table 2-2.
Based on the data, the genome size is estimated to be approximately 3 Mb including a large plasmid of
roughly 340 kb. This plasmid could be either linear or circular, and in single or multiple copies. This novel
mega-plasmid has been named p124.
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Table 2-2: Pulse Field Gel Analysis of Rhodococcus 124
AseI SspI Figure 2-2: Pulsed-field
Size of bands in kb 800 680 Gel Analysis of
380a 630b Rhodococcus 124 (on next
340 340 page)
210a 240 The size of the 124 genome was
195 130 analyzed by pulse-field gel analysis
175 100 with two enzymes, SspI (S) and AseI
130a 60 (A). Lambda PFG marker (M) is in
110 lane 1 and Uncut (U) 124 genomic
95 DNA is in lane 2. The 124 genome
90 contains a large plasmid of 340 Kb.
65
60
35
25
20
15
Total 2.75 Mb 2.8 Mb
Total with multiples 3.1-3.2 Mb 3.4c Mb
a Could be doublets due to intensity of ethidium bromide staining.
b At least a doublet. Used this in initial total.
C Total based on 630 kb band as a triplet
Knowing the approximate size of the genome facilitated the construction of a genomic library. The
first library attempted was an expression library. Construction of this library failed to produce clones with
insert sizes greater than 1.0 kb. Since the screen (see below) was designed to find a functional unit
comprised of more than one gene, this was unacceptable assuming that the average gene size is 1.0 kb
and the operon in question likely was comprised four genes. One reason for this difficulty could be due to
the high G+C content (- 65% as determined by sequence analysis - see below) and the incompatibility of
this G+C rich DNA in Escherichia coli whose G+C content is lower (-45-50%). Many different strain of E.
coli were employed in the attempts to circumvent this problem; however, these experiments were
unsuccessful.
To surmount this problem a genomic cosmid library was constructed. In order to prepare this library,
a new cosmid vector was constructed called pRhodoCOS. pRhodoCOS contains two COS elements and
an origin of replication that allows the plasmid to replicate in a broad range of hosts, including E. coli and
Rhodococcus. A vector that could replicate in a broad host range was needed to account for the
possibility that not all Rhodococcus genes would be expressed in E. coli. These genes would likely be
expressed in another Gram-positive host. Others have shown that not all Rhodococcus genes are
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expressed equally in E. coli, even from E. coli promoters (Asturias and Timmis 1993; Masai et al. 1995).
Using this new vector a genomic library of Rhodococcus 124 was constructed containing 286 cosmid
clones with approximately 30-40 kb inserts. Based on the genome size calculations, the library provides
approximately three-fold coverage of the Rhodococcus 124 genome.
Identification of Ring-Hydroxylating Dioxygenase Activity
A functional screen was used to identify cosmid clones that were carrying genes encoding ring-
hydroxylating dioxygenases. In some cases, other researchers have found that a ring-hydroxylating
dioxygenase will convert indole to indoxyl, which spontaneously dimerizes to form indigo (Ensley et al.
1983; Hart et al. 1992). Figure 2-3 shows the indigo formation assay reaction. Indigo accumulation in the
cells will cause the colonies to turn blue. E. coli is capable of converting tryptophan to indole via a
tryptophanase, providing an internal source of indole. We screened 286 transformants of E. co/i JM109,
each carrying a single cosmid from the library, for blue color development. Nine of the 286 strains turned
blue suggesting the presence of ring-hydroxylating dioxygenase activity. Cosmid DNA was isolated from
these nine strains and analyzed with a panel of restriction enzymes. The results suggest that these nine
clones contain overlapping portions of the genome (data not shown). The smallest clone, pR4, had an
insert of 20-30 kb and was chosen for further study.
The indigo formation assay in E. coli provides a preliminary screen for ring-hydroxylating dioxygenase
activity. This assay can be carried out in Rhodococcus provided that an external source of indole is
provided and the host strain itself does not have any inherent detectable ring-hydroxylating dioxygenase
activity (see Figure 2-3). A strain that does not change color in the presence of indole is R. erythropolis
SQ1 (Kesseler et al. 1996; Quan and Dabbs 1993). To determine whether pR4 encoded ring-
hydroxylating dioxygenase activity in Rhodococcus, the cosmid pR4 was transformed into R. erythropolis
SQ1. We found that R. erythropolis SQ1 harboring the plasmid pR4 will turn blue when exposed to indole
(Figure 2-4). This result strongly suggests that pR4 encodes a dioxygenase activity, and is consistent with
the results obtained in E. coli.
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Figure 2-3: Indigo Formation Assay Reaction
Above is the reaction pathway from tryptophan to indigo for E. coli, and the pathway from indole
to indigo for Rhodococcus. E. coli will take tryptophan from the media (e.g. LB media).
Rhodococcus require the addition of indole in the vapor phase in order to carry out these reactions.
Accumulated indigo in the cells (E. coli or Rhodococcus) will cause the cells to turn blue.
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Figure 2-4: Indigo Formation Assay
Rhodococcus SQl cells alone, transformed with pR4, or transformed with pR4-10, are treated with
6% indole dissolved in dimethyl formamide (DMF) placed on filter paper in the lid of the plate.
After a 24 hour incubation at room temperature the cells turn blue indicating indigo formation due
to a possible ring-hydroxylating dioxygenase activity.
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Indene Bioconversion Analysis
The primary screen in both E. coli and R. erythropolis SQ1 indicated that pR4 encoded an activity
that permitted the conversion of indole to indigo. To further characterize this putative dioxygenase activity,
we tested whether pR4 permitted oxygenation of indene by R. erythropolis SQ1. This is assayed in an
indene bioconversion, a growth assay carried out in the presence of indene supplied in an oil phase.
Indene is highly volatile and is not very miscible in water. The bioconversion of indene is measured by
analysis of extracted media by high pressure liquid chromatography (HPLC). A sample chromatogram of
the indene bioconversion products as visualized by HPLC is depicted in Figure 2-5.
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Figure 2-5: HPLC Indene Bioconversion Standards
This is a sample HPLC trace of the indene standards used in the analysis of indene bioconversion
products. From left to right the compounds and retention times are: trans-indandiol (8.92), cis-
indandiol (9.553), keto-OH-indan (10.82), indenol (14.587), indanone (17.32), and indene
(24.603). Indan oxide, when available as a standard, would have a retention time of
approximately 19.0 minutes. These are the approximate positions of the standards. Running
conditions vary with each set of samples and column thereby shifting the retention times slightly.
In addition to being unable to convert indole to indigo, wildtype R. erythropolis SQ1 is unable to
metabolize or oxygenate indene. Transformation of the pR4 cosmid into R. erythropolis SQ1 allows the
strain to oxygenate indene (Figure 2-6). A series of bioconversion products were identified from R.
erythropolis SQ1 (pR4) including cis-indandiol, keto-hydroxy-indan, 1-indenol, and 1-indanone. The
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production of trans-indandiol was not detected. Based on established pathways (Grund et al. 1995;
Warhurst and Fewson 1994; Zylstra 1994; Zylstra et al. 1988) and the proposed pathway in Rhodococcus
124 (Buckland et al. 1999; Chartrain et al. 1998) (Figure 2-1), production of the cis-indandiol is indicative
of dioxygenase activity. Keto-hydroxy-indan is produced by the dehydrogenation of the indandiol and its
presence suggests that there is also a dehydrogenase activity on the pR4 cosmid. When compared to
the product profile of Rhodococcus 124 (Figure 2-6), R erythropolis SQ1 (pR4) produces a subset of the
products produced Rhodococcus 124 in an indene bioconversion. This suggests that pR4 encodes only
some of the genes responsible for indene bioconversion in Rhodococcus 124.
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Figure 2-6: Indene Bioconversion Analysis of Rhodococcus SQ1(pR4)
The presence of indene metabolites were measured by HPLC analysis to determine if the
cosmid clone pR4 contained a dioxygenase activity that would utilize indene as a
substrate.
Rhodococcus 124 is known to produce two enantiomers of the cis-indandiol that are differentially
induced by naphthalene and toluene (Chartrain et al. 1998). To further characterize the dioxygenase
enzyme activity encoded by pR4, the chiral identity of the cis-indandiol produced by R. erythropolis
SQ1 (pR4) was examined by chiral HPLC analysis. This experiment was performed by M. Chartrain at
Merck Research Laboratories (Rahway, NJ). The results of this analysis show that only cis-(1 R,2S)-
indandiol, not cis-(1S,2R)-indandiol, was produced (data not shown). Based on these results, we
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conclude that pR4 carries a gene or genes that encode a specific dioxygenase activity and a possible
dehydrogenase activity.
Sequence Analysis
The next step in this analysis was to identify which regions of pR4 contained the genes involved in
the partial bioconversion of indene. Therefore, subclones of pR4 using a Sau3Al partial digest and re-
ligation were constructed to reduce the size of the clone to something more manageable. The indigo
formation assay was repeated to screen for subclones that retained ring-hydroxylating dioxygenase
activity. Three clones were identified that retained indigo forming activity in the screen and were
designated pR4-1 0, pR4-14, and pR4-20. Each subclone was subjected to an in depth restriction analysis
to determine the approximate size of the insert. The insert size of pR4-20 was highly variable in this
analysis therefore the clone was discarded. pR4-14 had an insert estimated to be 10.7 kb. Subclone
pR4-1 0 appeared to have the smallest insert of approximately 7.0 kb in length and was chosen for
sequence analysis. Furthermore subclone pR4-10, when transformed into R. erythropolis SQ1, promotes
the conversion of indene to cis-indandiol (data not shown - see Chapter 3 for more analysis and
discussion).
The entire insert of pR4-1 0 and approximately 4 kb of pR4 was subjected to DNA sequencing. The
insert of subclone pR4-10 was found to be 7036 bp in length, confirming the restriction enzyme digest
analysis. Consequently, approximately 11 kb of pR4 has been sequenced. The G+C content of the DNA
sequenced was approximately 65%. The sequence data were also subjected to extensive BLAST
searches using all of the available algorithms. Four open reading frames in the DNA sequenced were
found that have significant homology to genes found in dioxygenase operons (Figure 2-7).
Mulipic ORFs Multiple ORFs
124 Genome m$ 1
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Figure 2-7: Sequence Analysis and Genome Structure
The structure of the region encoding the dioxygenase was determined by sequencing pR4 and pR4-
10. The portion of pR4 sequenced is denoted by the thick line. In addition to the large and small
subunits of the dioxygenase, the dehydrogenase and putative aldolase, multiple open reading
frames (ORFs) were identified both upstream and downstream of the denoted gene cluster. None
of these ORFs showed significant homology to known genes in BLAST searches of the GenEMBL
databases.
The largest open reading frame detected is 1407 bp and shows homology to genes encoding the
large subunits of a variety of dioxygenases. Based on the indene bioconversion results and the proposed
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pathway, this gene is thought to correspond to the dioxygenase activity depicted in the lower portion of the
pathway (Figure 2-1) that is naphthalene-inducible and produces cis-(l R,2S)-indandiol. Hence we have
named this gene nidA for naphthalene-inducible dioxygenase system gene A. Analysis of the translated
open reading frame shows a potential Rieske type iron-sulfur binding center that exactly matches the
consensus sequence of C-x-H-R-G-x(8)-G-N-x(5)-C-x-Y-H-G found in proteins of this class (Figure 2-8)
(Mason and Cammack 1992). Generally, the large subunits of these dioxygenases also have iron-binding
sites comprised of two histidines and two tyrosines that are found toward the middle of the polypeptide;
however, the spacing of these amino acids is not well conserved in the known bacterial dioxygenases.
There are four histidines and three tyrosines near the middle of the polypeptide encoded by pR4, any of
which could contribute to a iron-binding site.
A F Consensus Rieske
CxERGxzxxxxxzGNxxxxxCxYiG Fe-S Center
80 E - I R G H L N A C R:H R G M Q V C R A E M G N A S H F R k P " G T Y S H T G S 109 NidA Rhodococcussp.124
90 G S I S V F L N Q C RHR G M R I C R A D G G N A K S F T C S Y H G W A Y D S A G 120 BphAl erythroplis
90 G S I S V F L N Q C R H R G M R I C R A D G G N A K S F TC S Y H G W A Y D S A G 120 BpdCl Rhodococcussp.M5
90 G S I S V F L N Q C R HR G M R I C R A D G G N A K S F T C S Y R G W A Y D S A G 120 BphAI R.globeruus
98 - S V R A F L N AR H RR G M R V C R A E S G N T K S F F T Y 8V G W A Y D T A G N 127 ORF5Sphingomonas RWI
90 - S I A V F L N Q:C R R G M R I C R S D A G N A K A F TC S Y X G W A Y D T A G N 119 TccAl Burkholderiasp.PS12
90 - - - A V F L N Q C R H RG M R I C R S D A G N A K A F T C S Y H G W A Y D T A G N L V 117 TcbAaPseudomonassp.PSI
73 - S I R A F L N V:C R H R G K T L V N A E A G N A K G F VC S Y H 0 W G F G S N G E 102 NahAcP.putidaG7
90 - - - A V F L N Q C RH G M R I C R A D AG N A K A F T C S Y WA Y D T A G N L V 117 TodCI P.puidaNCB9816-4
Figure 1-7: Rieske Iron-Sulfur Center of the NidA Dioxygenase Large Subunit
The consensus Rieske Iron-Sulfur Center is shown in bold at the top. Consensus residues are
highlighted in grey. The NidA Dioxygenase Large Subunit has a region that matches the
consensus (using PROSITE, Bairoch, 1992). Alignment was made using ClustalW with the
Lasergene program (DNA star, Madison, WI). The GenBank accession numbers of the protein
sequences are (from top to bottom): AF121905, D88020, U27591, X80041, AJ223219, U78099,
U15298, 484406, JO4996.
Next to nidA is a 519 bp open reading frame with homology to dioxygenase small subunit genes. We
have named this open reading frame nidB. It has no distinguishing features or motifs. The small subunit
of the dioxygenase is followed by another open reading frame of approximately 1.0 kb with homology to
cis-dihydrodiol dehydrogenases and we have named it nidC. Analysis of the derived protein sequence
shows that NidC has the characteristic C-terminal Y-x-x-x-K motif thought to be the active site of these
dehydrogenases (Figure 2-8) (Jornvall et al. 1995; Krozowski 1994; Persson et al. 1991). The NidC
dehydrogenase may also have a NAD' binding site in the N-terminal portion of the polypeptide. The
characteristic NAD' binding site is G-x-x-x-G-x-G and there is a distinct G-x-G-x-G-x-G motif in the N-
terminus of the dehydrogenase encoded by pR4 that aligns with other dehydrogenases (Figure 2-
9)(Jornvall et al. 1995; Krozowski 1994; Persson et al. 1991).
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Figure 2-8: Dehydrogenase Active Site in NidC Dehydrogenase
The consensus active site is shown in bold at the top. Consensus residues are highlighted in
grey.The active site is generally found in the middle towards the C-terminal portion of the protein.
The NidC dehydrogenase has a region that matches the consensus (using PROSITE, Bairoch,
1992). This region lies in the C-terminal portion of the protein. Alignment was made using
ClustalW with the Lasergene program (DNA star, Madison, WI). The GenBank accession
numbers of the protein sequences are (from top to bottom): AF121905, AJO06127, AF07931,
D17319, D32142, AJ006307, Y07655.
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Figure 2-9: NAD+ Binding Site in NidC Dehydrogenase
The consensus binding site is shown in bold at the top. Consensus residues are highlighted in grey.
The NidC dehydrogenase has a region that matches the consensus (using PROSITE, Bairoch,
1992). Alignment was made using ClustalW with the Lasergene program (DNA star, Madison,
WI). The GenBank accession numbers of the protein sequences are (from top to bottom):
AF121905, AJ006127, AF0793.1, D17319, D32142, AJ006307, Y07655.
The fourth open reading frame, which is located downstream of the nidC dehydrogenase gene, is 756
bp in length and exhibits weak homology to aldolase genes. We have named the putative aldolase gene
nidD. Since we do not have an assay for this activity the name assignment is provisional. The name
assignments of nidABC are based on homology and the indene bioconversion data. The regions
upstream and downstream of these four genes (nidABCD) contain open reading frames that exhibit no
significant homology to anything in the GenEMBL non-redundant databases. All four of the open reading
frames identified by homology appear to have ribosome binding sites (RBS) associated with them based
on the canonical RBS sites from E. coli (Shine and Dalgamo 1975).
All four of the gene identified by sequence homology were subjected to percent similarity and
phylogenetic analysis of their DNA derived protein sequences. The derived protein sequences were
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compared with the first five to seven most probable matches from the BLAST analyses. Figure 2-10
shows charts with the percent similarity of the Nid proteins to other similar proteins. On average, the Nid
proteins are approximately 30% similar over the entire length of the protein to other aromatic degradation
proteins. Notably, the average percent similarity for the putative aldolase is lower, around 24%. To get an
idea of the evolutionary relationships of the Nid proteins to these similar proteins a phylogenetic analysis
was conducted. It can be seen from Figure 2-11 that the Nid proteins diverge early from those proteins
with which they are most closely related.
Figure 2-10: Sequence Similarity of NidABCD and Related Proteins
Sequence similarity analysis of aligned DNA derived protein sequences was determined.
Alignment was performed using the CLUSTAL method with PAM250 residue weight table using
MegAlign software from the Lasergene program (DNA star, Madison, WI). Sequence similarity is
expressed as a percent and located to the right of the diagonal. A). The large subunit of the
dioxygenase is analyzed. The GenBank accession numbers for the indicated genes are (from top to
bottom): AF121905, D88020, U27591, X80041, AJ223219, U78099, U15298, 484406, J04996..
B). Analysis of the small subunit of the dioxygenase. GenBank accession numbers are (from top
to bottom): AF121905, U24277, S51758, D32142, AJ223219, 2822266, Q52439, P08085,
3184045, 484406, J04996. C). The dehydrogenase is analyzed. GenBank accession numbers for
the genes indicated are (from top to bottom): AJ006127, D32142, D17319, Y07655, AJ006307,
AF07931, AF121905, AJ006126. D). Analysis of the aldolase. GenBank accession numbers are
(from top to bottom): U09057, AB004059, AF010471, AF061751, AB000735, AF121905.
Figure 2-11: Phylogenetic Analysis of NidABCD and Related Proteins
Phylogenetic analysis of aligned DNA derived protein sequences with the highest homology to the
nid genes was conducted. Alignment was performed using the CLUSTAL method with PAM250
residue weight table using the MegAlign software from the Lasergene program (DNA star,
Madison, WI).. The x-axis of this unbalanced tree represents the number of substitution events,
thus describing the divergence between sequences. A). The large subunit of the dioxygenase is
analyzed. The GenBank accession numbers for the indicated genes are (from top to bottom):
D88020, X80041, U27591, U78099, U15298, J04996, AJ223219, AF121905, 484406. B).
Analysis of the small subunit of the dioxygenase. GenBank accession numbers are (from top to
bottom): P08085, J04996, 3184045, U24277, D32142, S51758, 2822266, Q52439, AJ223219,
AF121905, 484406. C). The dehydrogenase is analyzed. GenBank accession numbers for the
genes indicated are (from top to bottom): AF121905, AJ006127, AF07931, D17319, D32142,
AJ006307, AJ006126, Y07655. D). Analysis of the aldolase. GenBank accession numbers are
(from top to bottom): AF121905, AB000735, AF061751, U09057, AB004059, AF010471.
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Figure 2-10: Sequence similarity of NidABCD and related proteins
A. NidA Large Subunit of the Dioxygenase
Percent Similarity
1 2 3 4 5 6 7 8 9
1 29.2 29.2 29.2 28.7 31.0 29.9 26.9 29.3 1 NidA Rhodococcus sp. 124
2 126.9 99.4 99.8 34.2 72.1 71.6 28.5 71.6 2 BphAl R. erythroplis
3 126.9 0.4 99.4 34.2 71.9 71.4 28.5 71.3 3 BpdCl Rhodococcus sp. M5
4 126.9 0.0 0.4 34.2 72.1 71.6 28.5 71.6 4 BphAl R. globerulus
5 142.1 99.5 99.5 99.5 33.4 33.5 30.3 34.4 5 ORF5 Sphingomonas RW1
6 126.3 33.7 34.0 33.7 104.1 95.3 29.4 86.7 6 TecAI Burkholderia sp. PS12
7 128.0 33.2 33.5 33.2 102.9 3.7 29.8 88.7 7 TcbAa Pseudomonas sp. P51
8 160.9 136.2 137.3 136.2 139.6 138.0 139.7 29.6 8 NahAc P. putida G7
9 127.6 33.2 33.6 33.2 99.3 13.7 12.3 138.4 9 TodCI P. putida NCIB 9816-4
1 2 3 4 5 6 7 8 9
B. NidB Small Subunit of the Dioxygenase
Percent Similarity
1 2 3 4 5 6 7 8 9 10 11
1 32.9 32.9 32.4 32.9 35.8 32.9 29.5 30.1 22.0 29.5 1
2 110.6 64.5 95.7 37.5 48.4 56.7 77.5 78.6 17.1 77.5 2
3 110.6 45.8 66.1 38.1 52.2 56.5 63.4 64.0 18.3 63.4 3
4 112.8 4.4 43.0 38.6 50.0 56.7 79.1 79.7 16.6 79.1 4
5 102.8 95.0 96.0 93.2 39.2 43.2 40.3 39.8 21.6 40.3 5
6 102.1 82.8 74.9 78.4 96.0 66.1 50.0 50.0 17.2 50.0 6
7 112.8 62.4 61.8 62.4 84.6 43.0 56.7 55.6 21.2 56.7 7
8 127.6 26.7 46.8 24.5 93.2 78.4 62.4 93.0 17.6 100.0 8
9 122.4 25.2 45.8 23.8 93.2 78.4 64.8 7.3 17.6 93.0 9
10 160.3 212.0 200.0 212.0 197.0 200.0 183.2 202.0 202.0 17.6 10
11 127.6 26.7 46.8 24.5 93.2 78.4 62.4 0.0 7.3 202.0 11
1 2 3 4 5 6 7 8 9 10 11
NidB Rhodococcus sp. 124
IpbA2 R. erythroplis BD2
BphA2 R. globerulus
BphA2 Rhodococcus sp. RHAI
ORF G6 Sphingomonas str.RW1
IpbAb P. putida RE204
BphA2 Pseudomonas sp. KKS 102
BnzB P. putida
McbAb Ralstonia sp. JS705
NahAd P. putida G7
TodC2 P. putida NCIB 9816-4
C. NidC Dehydrogenase
Percent Similarity
1 2 3 4 5 6 7 8
1 33.7 37.2 33.3 33.8 42.8 12.3 31.0 1 NidC Rhodococcus sp. 124
2 115.0 45.9 54.8 98.1 55.6 11.5 55.2 2 IpbB Rhodococcus
3 106.1 84.1 41.0 46.4 54.5 10.9 41.4 3 BphB Sphingomonas aromaticicorans pNL1
4 116.0 66.5 97.8 54.0 67.9 11.6 72.5 4 BphB Pseudomonas sp. KKS 102
5 117.1 0.4 84.7 66.6 54.5 12.2 54.8 5 BphB Rhodococcus sp. RHAl
6 94.5 64.8 67.2 41.8 63.7 15.5 62.6 6 McbB Ralstonia sp.
7 342.0 393.0 328.0 335.0 383.0 328.0 11.9 7 EdoC Rhodococcus sp.
8 123.4 65.7 99.6 33.8 65.8 51.5 309.0 8 BphB P. putida OU83
1 2 3 4 5 6 7 8
D. NidD Aldolase
Percent Similarity
1 2 3 4 5 6
1 26.2 24.2 24.2 23.8 23.8 1 NidD Rhodococcus sp. 124
2 145.2 35.9 36.5 37.1 36.5 2 PhdJ Nocardioides sp. KP7
3 141.6 111.9 74.2 73.9 73.3 3 PhnE Burkholderia sp. RP007
4 158.9 111.2 30.4 98.2 95.8 4 NahE Pseudomonas putida plasmid
5 160.5 109.9 31.1 1.8 95.2 5 PahE P. putida st. OUS82
6 160.5 113.4 31.6 4.4 5.0 M 6 NahD P. putida
1 2 3 4 5 6
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Figure 2-11: Phylogenetic analysis of NidABCD and related proteins
A. Large Subunit of the Dioxygenase
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Discussion
Genomic analysis of Rhodococcus 124 by pulsed-field gel electrophoresis suggested that the genome
was approximately 3 Mb. Other strains of Rhodococcus and related organisms such as Corynebacterium
and Mycobacterium have been analyzed in this fashion. Genome sizes of actinomycetes appear to range
from 3 Mb to 7 Mb [Bigey, 1995 #521; (Pisabarro et al. 1998); Correia, 1994 #519; Bathe, 1996 #520;
Philipp, 1996 #522]. The size of Rhodococcus 124 is within the range of those strains previously
investigated, although it is smaller than other Rhodococcus strains analyzed to date. A large plasmid
named p124 was identified in Rhodococcus 124. It is unknown whether this plasmid is linear or circular.
Other have shown that Gram-positive and Gram-negative bacteria can have linear plasmids [Dabrock,
1994 #508; (Pisabarro et al. 1998); Picardeau, 1997 #498; Hinnebusch, 1993 #523] and circular plasmids
(Dabbs 1988) as part of their genomic content. To determine the structure of the p124 plasmid further
investigation is needed.
Using a functional assay in E. coi and DNA sequencing an 11.0 kb fragment of Rhodococcus 124
DNA was identified that encoded four genes (nidABCD) including a dioxygenase and a dehydrogenase
capable of breaking down indene to cis-(1 R,2S)-indandiol, 1 -indenol, 1 -indanone, and keto-hydroxy-indan.
Nine overlapping cosmid clones were identified that carry these genes. We believe that these genes
could be located on the large plasmid found in the strain. This plasmid could be in multiple copies thereby
accounting for the disproportionate number of clones identified. A preliminary investigation of this
possibility was carried out via Southern blotting of pulse-field gel separated DNA using the dioxygenase
gene nidA as a probe. Other aromatic compound degrading bacteria, including Pseudomonas,
Burkholderia, and Rhodococcus, have been found to have operons for aromatic catabolism located on a
plasmid separate from the rest of the genome (Aemprapa and Williams 1998; Dabrock et al. 1994; Fong
et al. 1996; Masai et al. 1997; Sanseverino et al. 1993; Shields et al. 1995). The preliminary results
suggested that the nidA dioxygenase may be located on the plasmid (data not shown). However, due to a
variety of technical issues this result has not been confirmed. Future experiments have been planned to
address this issue including plasmid isolation and screening for a plasmid-cured strain. It may also be
possible to transfer p124 to another strain by conjugation. Often these large plasmids containing aromatic
degradation pathways can be transferred from one strain to another by transconjugation (Nakazawa and
Yokota 1977; Shields et al. 1995; Williams and Worsey 1976). This method of analysis is being explored
by trying to transfer p124 to the heterologous host R. erythropolis SQ1 and screening for indene
bioconversion or indigo formation.
Bioconversion analysis suggests that the genes nidAB correspond to the subunits of the
naphthalene-inducible dioxygenase proposed for Rhodococcus 124 (Chartrain et al. 1998). When the
plasmid pR4 is transformed into the naive host R. erythropolis SQ1, the transformed strain only produces
the cis-(1R,2S)-indandiol when provided indene as a substrate (Figure 1). This finding strengthens the
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hypothesis that multiple dioxygenases produce the different indandiols in Rhodococcus 124 in a
stereospecific manner (Buckland et al. 1999; Chartrain et al. 1998). The lack of cis-(1 S,2R)-indandiol and
trans-(1 R,2R)-indandiol production by the naive R. erythropolis SQ1 containing pR4 also supports this
notion. The absence of cis-(1 S,2R)-indandiol suggests that there is a separate oxygenase that produces
this enantiomer. We believe this to be a toluene-inducible dioxygenase (Chartrain et al. 1998). The fact
that no trans-(1 R,2R)-indandiol was produced by R. erythropolis SQ1 (pR4) suggests that there is a third
enzyme in Rhodococcus 124 carrying out an oxygenation reaction producing this compound. This third
enzyme could be a monooxygenase that is inducible by naphthalene (Chartrain et al. 1998). Other
evidence that is consistent with our proposal that pR4 encodes a functional dioxygenase is the production
of indenol and indanone. It has previously been shown that indenol and indanone can be produced by
both naphthalene and toluene dioxygenases using indene as a substrate (Gibson et al. 1995; Wackett et
al. 1988). The formation of indenol and indanone in Rhodococcus 124 can now be attributed, at least
partially, to the nidAB dioxygenase we have identified. It is possible that the other oxygenases in the
system can contribute to the formation of these products as well. We are currently investigating substrate
utilization, gene deletion and complementation studies with the nidAB dioxygenase genes so that we may
control and modify this bioconversion pathway (see Chapter 4).
Lg Subunit Sm subunit Dehydrogenase Putative
Diox Diox Aldolase
nidA nidB nidC nidD
NidAB NidC
/ -,( AD~lND
NADH NAD
Indene cis-(1R,2S)-Indandiol 1 keto 2-hydroxy indan
Figure 2-12: Genes and Compounds
Depicted above are the genes identified on the cosmid clone pR4 from Rhodococcus 124. The
name nid stands for naphthalene inducible dioxygenase system. When these genes are expressed
in the naive host R. erythroplis SQ1 they enable the strain to carry out the reactions shown above.
All of the compounds can be detected by HPLC.
Bioconversion analysis suggests that pR4 carries a gene encoding a diol dehydrogenase. This is
evidenced by the fact that there is keto-OH-indan produced during a bioconversion using the strain R.
erythropolis SQ1 (pR4). Chemically, keto-OH-indan can be produced by the oxidation of cis-(1 R,2S)-
indandiol. Furthermore, the gene nidC identified by DNA sequencing of pR4 has homology to diol
dehydrogenases. Overall, the indene bioconversion analysis in conjunction with DNA sequence analysis
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has led to the model shown in Figure 2-12 showing the genes, their relative positions and the chemical
reactions for which the protein products are proposed to be responsible for.
Sequence analysis strongly suggests that the nidABCD genes belong to a family of genes capable of
degrading aromatic compounds. Comparison of the nidABCD dioxygenase system with other
dioxygenase systems in their overall gene organization suggests that the nid gene organization and genes
in Rhodococcus 124 are different from other dioxygenase operons. Some examples of the gene
organization of operons involved in aromatic compound degradation are given in Figure 2-13. By
sequence homology, these operons are some of the most closely related to the nidABCD genes. A
general pattern can be seen in the gene organizations. The nid genes appear to be divergent from this
general pattern. When the homologous sequences are aligned and subjected to phylogenetic analysis the
nid genes diverge early from their most homologous relatives (Figure 2-11). This is consistent with the
divergence seen in the organization of the open reading frames.
One way the nid genes are different from the general pattern is in the lack of an identifiable
reductase, ferredoxin, or catechol dioxygenase within the 11 kb of DNA sequenced. The ferredoxin and
the reductase components are required for electron transfer to the dioxygenase components in systems
that are similar to nidAB (Mason and Cammack 1992). Therefore it is reasonable to suspect that these
two components are needed for the dioxygenase system from pR4. This suggests that there may be as
yet unidentified genes for the ferredoxin, the reductase on pR4 or that these components are unnecessary
for this dioxygenase system. The region of pR4 potentially carrying these unidentified genes has been
partially delineated by the pR4-10 subclone since this subclone retains indene bioconversion activity
(Figure 2-7, and Chapter 3). Another possibility is that the nidAB dioxygenase subunits can borrow the
ferredoxin and reductase components from the R. erythropolis SQ1 host strain. It has been previously
demonstrated that the dioxygenase subunits from one system or hybrid dioxygenase subunits, can borrow
the ferredoxin and reductase components of another system thereby altering the activity of the
dioxygenase system (Beil et al. 1998; Furukawa et al. 1993; Hirose et al. 1994). In addition, it has been
demonstrated in Pseudomonas that the reductase component can be located elsewhere in the operon,
separated from the terminal dioxygenase subunits by a number of intervening genes (Kikuchi et al. 1994),
or scattered in the genome (Armengaud et al. 1998). However, if the later were the case in Rhodococcus
124 a functional dioxygenase might not be identified in our functional screen. There are plans for others to
further investigate the unidentified open reading frames in the 124 nid region in functional studies such as
the creation of nested deletions to determine the minimal functional unit.
The inducible production of different stereoisomers of indandiol by nidAB and the other oxygenases
implies that these enzymes may be subtly different from each other. Since indene cannot be used as a
carbon source by the 124 strain (Chartrain et al. 1998) and is therefore not likely a natural substrate for
these enzymes, the different enantiomers of indandiol may be the consequence of steric constraints on
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Figure 2-13: Comparison of Gene Organization of Dioxygenase Systems
Four different dioxygenase systems that are similar to. the Rhodococcus 124 nid region system by
homology are compared to each other by their gene organization.
a Asturias, J. A., E. Diaz, and K. N. Timmis. Gene 1995 156(1): 11-18
b Wang, Y. et al. Gene 1995 Oct 164(1): 117-122
' Fukuda, M., et al. Biochem Biophys Res Commun 1994 July 202(2): 850-856
d Takizawa, N. T. lida, K. Yamauchi, S. Satoh, Y. Wang, M. Fukuda, and H. Kiyohara. Direct
submission to Genbank, accession number: D84146
indene in the active site of these enzymes. Alternatively, the oxygenases could have different
mechanisms of oxygenation resulting in the production of a specific enantiomer. This has been partially
demonstrated for the toluene monooxygenases. The final product of the upper pathway of toluene
degradation is the same in many strains, but the method by which toluene is oxygenated by a
monooxygenase varies (Zylstra 1994). The enzyme mechanisms of previously identified bacterial
dioxygenases have not yet been determined. We are in the process of identifying the genes for the other
oxygenases in 124 in order to further investigate the stereospecificity of product formation.
Many strains of Rhodococcus are capable of breaking down aromatic compounds. Rhodococcus 124
is unique in that it employs at least three different types of oxygenases capable of acting upon indene.
63
This bioconversion is stereospecific and inducible. The gene structure for the Rhodococcus 124
naphthalene-inducible dioxygenase is unlike any dioxygenase gene cluster identified to date. We are
currently investigating the other genes on this cosmid clone in order to better understand this dioxygenase
system and indene bioconversion in Rhodococcus 124. In our study of bacteria capable of stereospecific
bioconversion, we hope to develop efficient and controllable methods of producing important chiral
substances and to gain a better understanding of how this organism and others like it metabolize aromatic
substrates.
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Chapter Three: Characterization of the nidC Diol Dehydrogenase from
Rhodococcus strain 124
Abstract
Part of the indene bioconversion pathway in Rhodococcus strain 124 is carried out by the protein
products encoded by the genes nidABC. Genetic and biochemical analyses demonstrate that the nidC
gene encodes a functional diol dehydrogenase. The NidC dehydrogenase is stereospecific for cis-
(1 R,2S)-indandiol, one of three indandiols produced during an indene bioconversion in Rhodococcus
strain 124. In nidC deletion mutant studies we uncovered a second diol dehydrogenase activity capable of
utilizing cis-(1 R,2S)-indandiol as a substrate. This underlying activity is naphthalene-inducible.
Introduction
Bacteria, with their highly evolved ability to metabolize a wide variety of compounds, are a resource for
enantiospecific precursors for biologically active products (Collins 1997; Patel 1997). When indene is
supplied as a substrate, Rhodococcus strain 124 is capable of producing two compounds which can be
used as precursors to the HIV protease inhibitor indinavir sulfate (Buckland et al. 1999; Chartrain et al.
1998). Figure 3-1 shows the proposed pathway of indene bioconversion in this system. Chartrain and
colleagues proposed that Rhodococcus strain 124 produces three different indandiols via three separate
stereospecific oxygenase systems (Chartrain et al. 1998). Many dioxygenase systems have been shown
to exhibit stereospecific oxygenation (Boyd et al. 1989; Hamberg et al. 1994; Lee 1997; Resnick 1994).
Some bacteria, including Pseudomonas and Rhodococcus, have dioxygenase systems that exhibit
stereospecific oxygenation of indene (Allen 1997; Wackett et al. 1988). The oxygenation of indene in
Rhodococcus strain 124 is followed by the oxidation of the indandiol products to keto-OH-indan.
Generally, oxidations of this type are carried out by a diol dehydrogenase (Zylstra 1994). It has not been
determined whether a single promiscuous dehydrogenase acts upon the different indandiols in
Rhodococcus 124, or whether there are multiple stereospecific dehydrogenases in this system.
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Figure 3-1: Proposed Indene Bioconversion Pathway in Rhodococcus strain I24
Genes encoding the naphthalene dioxygenase (nidAB) and a diol dehydrogenase (nidC) account for
part of the indene bioconversion pathway. They were identified in a screen using a functional
assay (see Chapter Two).
From a genomic library of Rhodococcus strain 124, we isolated genes encoding several enzymes
involved in the bioconversion of indene including the large and small subunits of a naphthalene-type
dioxygenase (nidAB), and a diol dehydrogenase (nidC). These genes were isolated on a single cosmid
(pR4) that was identified via an indigo formation assay (Chapter Two)(Treadway et al. 1999). We
demonstrated that when nidAB are expressed in a heterologous host indene is stereospecifically
oxygenated to cis-(1 R,2S)-indandiol. Furthermore, the cis-(1 R,2S)-indandiol can be oxidized to keto-OH-
indan when nidC is expressed. The NidC dehydrogenase is approximately 32% homologous to various
diol dehydrogenases including BphB from Rhodococcus sp. strain RHA1, BphB from Pseudomonas sp.
strain KKS1 02, and BphB from Pseudomonas putida OU83 (Treadway et al. 1999).
To better understand and control indene bioconversion in Rhodococcus 124 we wanted to further
characterize the dehydrogenase encoded by nidC both genetically and biochemically. In this chapter we
show through a variety of in vitro and in vivo assays that nidC encodes an enzyme that has diol
dehydrogenase activity. Furthermore, we demonstrate that this activity is stereospecific for the substrate
cis-(1 R,2S)-indandiol. We also investigate the consequences of deleting this gene in the host strain
Rhodococcus 124. We discuss the implications of these findings on the proposed model for indene
bioconversion in this strain and strategies for manipulating the indene bioconversion.
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Materials and Methods
Reagents
All strains used in this study are listed in Table 3-1. The plasmids used in this study are listed in Table
3-2. All chemicals were reagent grade and purchased from Sigma (St. Louis, MO) unless otherwise
noted. The cis-(1 R,2S)-dihydro-naphthalenediol was obtained from Fluka (Milwaukee, WI). The cis-
(1 R,2S)-indandiol and trans-(1 R,2R)-indandiol were synthesized as described below. The cis-(1 S,2R)-
indandiol was a gift from M. Chartrain and colleagues at Merck Research Laboratories (Rahway, NJ). All
media components were purchased from Difco (Detroit, MI) unless otherwise noted.
Table 3-1: Strains
Strains Description Reference
Rhodococcus 124 Converts indene to indandiol, orange colonies Buckland et al., 1998
R. erythropolis SQ1 Easily transformable isolate of R. erythropolis Qwan and Dabbs, 1993
Rhodococcus KY 1-3 Spontaneous mutant of Rhodococcus 124 with K. Yanagimachi (in
modified indene bioconversion profile preparation)
Rhodococcus ST-1 Rhodococcus 124 AnidC This work
Escherichia coli JM109 endAl, recAl, gyrA96, thi, hsdRJ7, (rk-, mk+), Yanisch-Peron, C., Viera,
relAl, supE44, X-, A(lac-proAB), [F', J., and Messing, J., 1985
traID36, proAB, lacIZAM15]
Escherichia coli S17-1 reck, res~, mod, proline auxotrophy, RP4 2- Simon et al., 1983
Tc:mu-km::Tn7, Kans, TpR, SmR
Escherichia coli MM294- Nalidixic acid resistant derivative of E. coli Eric Dabbs (personal
4 MM294 (Bachmann et al. 1987) communication)
DNA Manipulation and Transformation
All DNA restriction digests and manipulations were carried out using standard methods (Sambrook et
al. 1989). Enzymes were purchased from New England Biolabs (Beverly, MA). Plasmid DNA was
prepared using the Wizard Maxiprep Kit or Miniprep Kit from Promega (Madison, WI), or by boiling lysis
(Sambrook et al. 1989). All gel purifications of DNA fragments were executed with the Gene Clean IlIl Kit
from Bio101 (Vista, CA) following the manufacturer's instructions. Rhodococcus erythropolis SQ1was
transformed via electroporation as previously described (Treadway et al. 1999). Escherichia coilJM109
(Yanisch-Perron et al. 1985) was also transformed via electroporation (Sambrook et al. 1989).
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Table 3-2: Plasmids
Plasmids
pAL231
pAL235
pAPE12
pCR2.1-Topo
pCR-Script
pR4
pR4-10
pST108
pST109
pST1 12
pST114
pST1 16b
pST117
pST119
pSUP301
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Description
AmpR, colEI ori, tsr gene from pGM160
(Wohlleben et al., 1989) was ligated as an
EcoRI-SmaI fragment into the EcoRI and
EcoRV sites of a pCRScript (Strategene, La
Jolla, CA) derivative
KanR, AmpR, colE ori, RP4 mobility element
in pCR2. 1-Topo
KanR, NG2 ori, PTRC and lacPq from
pTRC99a
KanR , AmpR, colEl ori
ApMR, colEl ori
KanR, NG2 ori, 124 genomic cosmid clone
containing nidABCD
KanR, NG2 ori, Sau3a pR4 subclone
containing nidAB
KanR , AmR, colEI orn, the 1.1 kb XbaI-NsiI
fragment from pST 112 containing the
upstream and downstream regions of nidC
inserted into pST 114 cut with XbaI and NsiI
KanR, AmpR, ThioR, colEI ori, the tsr gene
from pAL231 on a 1.14 kb BspJ20I-PstI
fragment ligated into pST108 cut with NotI
and NsiI
KanR, AmpR, colEl, derivative of pCR-
Topo2.1 with 1.1 kb PCR fragment of 5'
upstream region of pR4 dehydrogenase nidC
using primers DH-1 and DH-2
Kan R, AmpR, colEl, derivative of pCR-
Topo2.1 with 1.4 kb PCR product containing
the 3' downstream region of the pR4
dehydrogenase nidC using primers DH-3 and
DH-4
Kan R, AmpR, colEl, derivative of pCR-
Topo2.1 using primers 5'-dehydro and 3'-
dehydro to amplify pR4 dehydrogenase nidC
KanR , ,colEI, the 1.0 kb nidC gene as
an EcoRI fragment from pST1 16b inserted
into pAPE12 digested with EcoRI
AmpR, ThioR, colEI ori, the RP4 mobility
element on a PstI-SpeI fragment from
pAL235 inserted into pST109 cut with PstI
and XbaI
Kan R, AmpR, pACYC177 with RP4 mobility
element
Reference
This study
This study
Guillouet et al., 1999
Invitrogen (Carlsbad,
CA)
Strategene (La Jolla, CA)
Treadway et al., 1999
Treadway et al., 1999
This study
This study
This study
This study
This study
This study
This study
Simon et. al., 1983
Plasmid Construction
For the polymerase chain reaction (PCR) (Saiki et al. 1986) Taq polymerase, Taq buffer and
nucleotides were purchased from Boehringer Mannheim (Indianapolis, IN) and used according to the
manufacturer's instructions. The cycle conditions used with each PCR reaction are noted with each
construction. All PCR reaction parameters have a 5 minute 950C pre-cycle and a 10 minute 720C post-
cycle unless otherwise stated. Sequences of the PCR primers used in this study can be found in Table 3-
3. Primers were purchased from Gibco BRL (Grand Island, NY).
Table 3-3: PCR Primers
Primer Name Primer Sequence
SLT-8 5'- GGAAGCGCCCCCTCCACGGTG-3'
5'-dehydro 5'- GGAATTCATGAGCATCATCCACAACGA-3'
3'-dehydro 5'- CCGAATTCGCCGTCGCTGTTGATGAT-3'
DH-1 5'-AGTACTTCTAGAGCATGCCGGAGAACATCGTCGA-3'
DH-2 5'- TACGTAATGCATGTAGGCTCCTCCGTCACATGATCA-3'
DH-3 5'- AGGAGCCTACATGCATTACGTAGCGGCCGCACCATCATCAACAGCGA-3'
DH-4 5'- CCTGTGTAACTTCTGACGCA-3'
DehKO-1 5'- GAACTCGGACGTTCGTCGGTAG-3'
DehKO-2 5'- GATTCGCTGGAGGACTACCTC-3'
inThio-1 5'- CTCGACCTCGATTCGTCAGTG-3'
inThio-2 5'- GACGTCCTCGATCAACGTTG-3'
MunI-mob 5'- CCAATTGATCCTTTGTCCGGTGT-3'
XbaI-mob 5'-GCTCTAGAGATCGTGGCATCACCGA-3'
The plasmid pAL231 was made by excising the tsr gene from pGM160 (Wohlleben et al. 1989) as an
EcoRl-Smal fragment and ligating it into the EcoRI and EcoRV sites of a pCRScript (Strategene, La Jolla,
CA) derivative. The plasmid pAL235 was constructed as follows. The RP4 mob element was amplified
from pSUP301 (Simon et al. 1983) using primers Muni-mob and Xbal-mob. 5 % Dimethyl sulfoxide
(DMSO) was included in the PCR reaction mixture. The mixture was first heated to 940C for five minutes
and then cycled thirty times with each cycle comprising 1 min at 940C, 4 min at 520C, and 3 min at 720C.
A final incubation for 10 min at 720C was included to ensure completion of the final extension products.
The 1.0 kb product was cloned into the pCR2.1 -Topo vector from the pCR2.1 -Topo-TA Cloning Kit
(Invitrogen, Carlsbad, CA) following the manufacturer's instructions. The insert in pAL235 is oriented such
that the Xbal site from the Xbal-mob primer is adjacent to the Xbal site in the polylinker of the pCR2.1 -
Topovector.
pST 16b was constructed via PCR using pR4 as the template DNA to amplify the 1.0 kb nidC
dehydrogenase gene with primers 5'-dehydro and 3'-dehydro. The cycle profile was 30 cycles at 950C for
1 minute, 500C for 1 minute, and 720C for 2 minutes. The gel-purified PCR product was cloned into the
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pCR2.1-Topo vector from the pCR2.1-Topo-TA Cloning Kit (Invitrogen, Carlsbad, CA). pST117, the
dehydrogenase expression construct, was made by ligating a 1.0 kb EcoRI fragment from pST 16b that
contains the nidC dehydrogenase into pAPE12 (Guillouet et al. 1999) that had been digested with EcoRl
and treated with shrimp alkaline phosphatase (Boehringer Mannheim, Indianapolis, IN).
Construction of the dehydrogenase knock-out construct was carried out in a series of steps. A 1.1 kb
region upstream of the nidC dehydrogenase was amplified by PCR using primers DH-1 and DH-2 using
pR4 as a template. The PCR reaction profile included 30 cycles at 950C for 30 sec, 550C for 30 sec, and
720C for 1 min. The PCR product was gel purified and ligated into pCR2.1-Topo as described above.
The resulting plasmid was named pST1 12. A 1.4 kb fragment of DNA from the region downstream of the
nidC was amplified using pR4 as the template and primers DH-3 and DH-4. DMSO (5%) was added to
the PCR reaction. The cycle profile included 30 cycles at 950C for 1 min, 470C for 1 min, and 720C for 2
minutes. The PCR product was gel-purified and ligated into pCR2.1-Topo as described above to form
pST1 14. pST1 08 was constructed by inserting the 1.1 kb Xba l-Nsi I fragment from pST1 12 (containing
the 5' upstream region) into pST1 14 digested with Xba I and Nsi 1. The tsr (thiostrepton resistance) gene
was inserted between the upstream and downstream regions, replacing the entire dehydrogenase open
reading frame. The tsr gene was obtained as a 1.14 kb Bsp1201-Pst I fragment from pAL231, and
inserted into pST1 08 cut with Not I and Nsi I. The 1.0 kb Pst I-Spe I fragment of pAL235 containing the
RP4 mobility element was ligated to the 6.4 kb Pst I-Xba I fragment of pST1 09 to produce the final
plasmid for making the knock-out, pST1 19.
Indandiol Biosynthesis and Purification
Strain Rhodococcus KY1 -3 (K. Yanagimachi, in preparation) was used to synthesize trans-(1 R,2R)-
indandiol and strain R. erythropolis SQ1 (pR4) was used to synthesize cis-(1 R,2S)-indandiol. A VirTis
Omni-Culture base (The VirTis Company, Gardiner, NY) with a New Brunswick 2.0 liter capacity vessel
(New Brunswick Scientific Co., Inc., Edison, NJ) and custom-made head plate were used. The
fermentation was conducted at 30 t 1 *C with an agitation speed of 1000 5 rpm. The pH was monitored
with a combination electrode (Cole-Parmer Instrument Co., Vernon Hills, IL) with a B&C Electronics
controller (pH 7615, B&C Electronics, Milano, Italy), and maintained at 7.0 ± 0.5 by addition of sterile 2 N
NaOH or 2 N HCI via a Masterflex variable speed modular peristaltic pump electrode (Cole-Parmer
Instrument Co., Vernon Hills, IL). The filter-sterilized air feed was maintained at 1.0 liter/min with Cole-
Parmer gas mass flow controllers electrode (Cole-Parmer Instrument Co., Vernon Hills, IL).
Medium K (Buckland et al. 1999) was used for the fermentation except that the glycerol was replaced
with 20 g/L glucose (Fisher, Fair Lawn, NJ), the FeS0 4-7 H2 0 was omitted, and 150pg/mI kanamycin was
added if appropriate. When the culture reached an OD600 of 15 (UVIKON 810 spectrophotometer,
Kontron Instruments, Zurich, Switzerland) indene was continuously added through an air delivery system
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that consisted of two air streams delivered through Teflon tubing: one air stream bubbled through 200 ml
indene and then combined with another air stream to dilute the indene air concentration (Figure 3-2). The
flow rates of each air stream were adjusted for a total flow rate of 1.0 L/min with approximately 150 PPM
indene (measured using a PE Photovac 2020 photo-ionization air monitor, PE Photovac, Markham,
Ontario, Canada, set with a response factor of 0.3).
Indene metabolite concentrations were monitored every 12 hours using the reverse-phase HPLC
assay (see below). 1.0 mi samples from the fermentor were extracted with 3 ml MilliQ water and 6 ml
HPLC grade isopropyl alcohol (Mallinckrodt Inc, Paris, KY), mixed, and centrifuged at 2455 x g. The
supernatant was filtered using 0.2 pm PVDF 13 mm syringe filters (Alltech, Deerfield, IL) before HPLC
analysis. The fermentation was stopped when the indandiol concentration reached approximately 1.0 g/L.
The cells were centrifuged for 10 minutes at 15344 x g. The supernatant was filtered through a Gelman
Sciences Suporcap-50 0.2 pm sterile filter (Gelman Sciences, Ann Arbor, MI) before purification. The
indandiol in the supernatant was purified using the protocol of Chartrain and colleagues (Chartrain et al.
1998) except that ethanol was substituted for methanol as the eluant. Each indandiol obtained was at
least 99% pure as determined by the chiral assay of Chartrain and colleagues (Chartrain et al. 1998).
Preparation of cell lysate
A 200 ml LB culture with 150pg/ml kanamycin and 0.8 mM isopropyl--D-thiogalactopyranoside
(IPTG) inoculated with Rhodococcus SQ1 (pST1 17) cells was grown for two days to an OD600 of 3.0
(Spectronic 20 Genesys Spectrophotometer, Spectronic Instruments, Rochester, NY). Cells were
harvested by centrifugation for 10 min at 4000 x g. Cells were then washed in 25 ml of PEG Buffer [0.5 M
potassium phosphate buffer (pH 7.6),10% ethanol, 10% glycerol] and recentrifuged at 4000 x g for 10
minutes. Cells were resuspended in PEG buffer containing Complete Protease Inhibitor (Boehringer
Mannheim, Indianapolis, IN) to an OD60 0 of 1000. The cell suspension was lysed using a mini-French
Press cell (Spectronic Instruments NY, NY) set at 14,000 psi. The lysate was cleared via centrifugation at
47000 x g for 20 minutes. The protein concentration was determined using the Bradford assay using
bovine serum albumin as the standard (Bio-Rad Laboratories Hercules, CA) following the manufacturer's
instructions.
Dehydrogenase in vitro assay
Enzyme activity was determined by monitoring NADH production at 340 nm using a HP 8452A Diode
Array Spectrophotometer (Hewlett Packard, Wilmington, DE). At its final concentration the reaction
contained 0.1 mM potassium phosphate buffer (pH 7.6), 1.0 mM NAD*, 10 mM diol substrate, and 340 pg
total lysate protein in a volume of 1.0 ml. The diol substrates included: cis-(1 R,2S)-indandiol, cis-(1 S,2R)-
indandiol, cis-(1 R,2S)-dihydro-naphthalenediol, R-styrene glycol, and S-styrene glycol.
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Figure 3-2: Indene Delivery System for Fermentations
This figure is courtesy K. Yanagimachi. Air is bubbled through a'flask of indene and the indene
saturated air is then fed to the fermentor. The indene was measured using a photo-ionization
detector at entry and exit.
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In vivo Dihydrodiol Breakdown Experiments
25 ml LB cultures of R. erythropolis SQ1 and derivative strains were grown for 12 hours at 30*C. The
cultures contained 150 pg/ml kanamycin and/or 0.8mM isopropyl-s-D-thiogalactopyranoside (IPTG), if
appropriate. For each culture, a 1.0 ml sample was taken. Subsequently, 2.5 mg of dihydrodiol was
added directly to the medium and resuspended. Another 1.0 ml sample was taken immediately after
resuspension. Samples were taken at regular intervals thereafter. To each sample 1.0 ml of HPLC grade
isopropanol (Mallinckrodt, Paris, KY) was added. The cell suspension was vortexed and centrifuged for 5
min. Samples were filtered with 0.22 pm PVDF syringe filter (Alltech, Deerfield, IL) and analyzed via
HPLC as described below. Analysis of cis-(1 R,2S)-indandiol breakdown in Rhodococcus ST-1 and
Rhodococcus 124 was performed as described above except that 10 pg/ml thiostrepton was added to the
LB culture of Rhodococcus strain ST-1. Colony forming units (CFU/ml) were determined by plating serial
dilutions of the cultures on LB plates supplemented with 10 gg/ml thiostrepton if appropriate. The plates
were grown at 300C and the colonies were counted after 2-3 days of growth.
R. erythropolis SQ1 Indene Bioconversions
R. erythropolis SQ1, R. erythropolis SQ1 (pR4) and R. erythropolis SQ1 (pR4-1 0) fermentations were
carried out using the fermentation apparatus as described in the indandiol biosynthesis section. The
fermentation medium was a defined medium called Medium Rare containing 40 g/L glucose (Fisher, Fair
Lawn, NJ), 1.4 g/L (NH4)2SO 4 , 1.0 g/L MgSO4-7H20, 0.015 g/L CaCI 2-2H20 (Mallinckrodt Inc., Paris, KY),
1.0 g/L MOPS buffer, 1.0 ml/L A9 trace elements solution, 1.0 ml/L Stock A solution, 35.2 ml/L 1.0 M
phosphate buffer, 150 pg/ml kanamycin (if appropriate), and 1.0 ml/L polypropylene glycol (MW 2000)
(Acros Organics, NJ). The A9 trace elements solution contains 0.5 g/L FeSO 4-7H20 (Mallinckrodt Inc.,
Paris, KY), 0.4 g/L ZnSO4-7H20 (Fluka, Buchs, Switzerland), 0.02 g/L MnSO4-H20 (Mallinckrodt Inc.,
Paris, KY), 0.015 g/L H3B0 3 (Fisher, Fair Lawn, NJ), 0.01 g/L NiCl 2-6H20 (Mallinckrodt Inc., Paris, KY),
0.05 g/L CoCl 2-H20 (Mallinckrodt Inc., Paris, KY), 0.005 g/L CuC 2-2H20 (Mallinckrodt Inc., Paris, KY), and
0.25 g/L EDTA. The Stock A solution contains 2.0 g/L NaMoO4-2H20 and 5.0 g/L FeNa-EDTA (J.T.
Baker, Phillipsburg, NJ). The 1.0 M phosphate buffer contains 113 g/L K2HPO4 and 47 g/L KH 2PO 4
(Mallinckrodt Inc., Paris, KY).
The fermentation and indene feed was initiated as described above. 1.0 ml samples were taken three
times a day for three days during the indene feed. The samples were extracted and filtered as described
above. Indene metabolite concentrations were measured using the reverse phase HPLC assay.
Reverse Phase HPLC Assay
An HPLC system (Waters 2690 Separation Module with Waters 996 Photodiode Array Detector,
Waters Corporation, Milford, MA) equipped with a YMC CombiScreen C8 column (4.6 mm ID x 50 mm, S-
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5 pm, 120 A pore size) (YMC, Inc., Wilmington, NC) was used. Separation was achieved using a
gradient-based elution with a mobile phase of acetonitrile (Mallinckrodt Inc, Paris, KY) and water delivered
at a flow rate of 3.0 ml/min. The first two minutes of the HPLC were run isocratically at 90% water and
10% acetonitrile. The amount of acetonitrile was increased to 30% for the next minute and raised to 90%
over the following minute. Compounds were detected at 220 nm at 230C. The following elution times
were obtained: trans-indandiol at 1.3 min, cis-indandiol at 1.5 min, 1-keto 2-hydroxy-indan at 1.8 min, 1-
indenol at 3.2 min, 1-indanone at 3.5 min, and indene at 4.2 min. HPLC standards were gifts from
Chartrain and colleagues at Merck Research Laboratories (Rahway, NJ).
Construction of Rhodococcus 124AnidC
Creation of a nidC null mutant was carried out by introducing the knock-out plasmid pST1 19 into
Rhodococcus strain 124 via transconjugation using filters as previously described (Schafer et al. 1990). E.
coli S17-1 (Simon et al. 1983) harboring pST1 19 was used as the donor strain, and Rhodococcus strain
124 was the recipient strain. Transconjugants were selected on LB plates supplemented with 10 gg/ml
thiostrepton and 10 pg/ml nalidixic acid after 5-6 days at 300C.
Genomic DNA was prepared from each AnidC candidate as described previously (Chapter
Two)(Treadway et al. 1999). PCR reactions for analysis of candidate deletion strains included 5% DMSO.
The following primers were used in this analysis (Table 3-3): SLT-8, DH-1, DH-4, DehKO-1, DehKO-2,
inThio-1, and inThio-2. The cycle profile was 950C for 5 minutes, followed by 30 cycles of 950C for 1
minute, 49 0C for 1 minute, and 720C for 3 minutes. The 30 cycles were followed by a 10 minute extension
cycle at 720C. The PCR products were analyzed by electrophoresis on a 1% agarose gel. The PCR
products were also analyzed by restriction digest using the enzymes SaA and EcoRV.
Indene Bioconversions of Rhodococcus 124 and Rhodococcus ST-1
Uninduced indene bioconversions of Rhodococcus 124 and Rhodococcus ST-i were carried out in a
batch fermentations (apparatus described above). The conditions and sampling were the same as
described above for the Rhodococcus SQ1 fermentations except that 10 pg/mI thiostrepton was added to
the culture of Rhodococcus ST-1.
The naphthalene-induced bioconversions were conducted in screw capped flasks. A 500 ml culture in
Medium Rare (see above) with 10 pg/ml thiostrepton, if appropriate, and 5 g/L of naphthalene was grown
at 300C until approximately an OD600 of 1.0. The culture was separated into three 100 ml aliquots into 500
ml screw capped flasks. Indene was added directly to the culture (no oil) in 20 pl aliquots, every 24 hours.
1.0 ml samples were taken every 12 hours for HPLC analysis. Samples were extracted with 1.0 ml of
HPLC grade isopropanol (Mallinckrodt Inc., Paris, KY), filtered with 0.22 pm PVDF syringe filter (Alltech,
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Deerfield, IL), and analyzed by HPLC as described above. 1.0 ml samples were taken every 24 hours to
monitor the optical density.
Indene Bioconversion Induction Assay
500 ml Medium Rare (see above) cultures with 10 pg/ml thiostrepton, if appropriate, with and without
5 g/L of naphthalene were grown at 300C for 43 hours. The cells were centrifuged for 10 minutes at 4000
x g. Cells were washed in induction buffer ( 10 g/L MOPS, 10 g/L glucose, 0.1 g/L FeSO 4 7H 20) and
recentrifuged. The cells were resuspended in 40 ml of induction buffer in a 500 ml screw capped flask.
20 p. of indene was added directly to the flask. Samples (1.0 ml) were taken at regular intervals for two
hours. 1.0 ml of HPLC grade isopropanol (Mallinckrodt Inc., Paris, KY) was immediately added to each
sample. The samples were vortexed, filtered with 0.22 pm PVDF syringe filter (Alltech, Deerfield, IL), and
analyzed by HPLC as described above.
Results
In vitro Dihydrodiol Enzyme Assay
We previously demonstrated that expression of nidABC promotes the conversion of indene to cis-
(1 R,2S)-indandiol, keto-OH-indan, 1 -indenol, and 1 -indanone (Treadway et al. 1999)(Chapter 2). Keto-
OH-indan is believed to be the product of cis-(1 R,2S)-indandiol dehydrogenation. To further characterize
the NidC dehydrogenase thought to be responsible for this reaction we constructed an inducible plasmid,
pST1 17, that would express only the dehydrogenase. To determine whether this gene encoded a
functional dehydrogenase an in vitro enzyme assay was developed. For these assays we utilized a host
strain, R. erythropolis SQ1, that is unable to metabolize indene or its derivatives. We transformed the
plasmid pST1 17 into the naive host R. erythropolis SQ1, grew the transformed R. erythropolis
SQ1 (pST117) cells in the presence of the inducer (IPTG), and prepared cleared crude lysates. We
monitored the dehydrogenation reaction by recording the production of NADH using spectrophotometric
analysis at 340 nm. We chose cis-(1 R,2S)-dihydro-naphthalenediol as the substrate for the initial enzyme
assays. This substrate was chosen because we believe that the dehydrogenase is associated with a
naphthalene-type dioxygenase and that cis-(1 R,2S)-dihydro-naphthalenediol may be the natural substrate
of this enzyme. Naphthalene can be used as a carbon source for this strain, whereas indene can not
(Chartrain et al. 1998).
Each enzyme assay reaction set contained the following: a blank with no lysate, a negative reaction
with no substrate, and the positive reaction with substrate. We found that the NidC dehydrogenase
displayed enzyme activity and can utilize cis-(1 R,2S)-dihydro-naphthalenediol as a substrate (Figure 3-3
and Table 3-4). Using cis-(1 R,2S)-dihydro-naphthalenediol as the substrate, standard curves for the
enzyme activity with regards to substrate concentration and enzyme concentration (in this case total
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protein from crude lysate) were determined (Figure 3-3). The effect of NAD' concentration was also
determined (data not shown); the concentration of NAD' used in these assays is not limiting. All
subsequent enzyme assays were based on this information. Since the dehydrogenase is not purified,
enzyme activity is assessed on a plus or minus basis in all assays henceforth. Multiple assays were
performed to show that the assay is reproducible.
In order to test the proposed model of indene bioconversion (Figure 3-1), we investigated the
substrate specificity of the dehydrogenase in regards to the different indandiols produced by Rhodococcus
124 during an indene bioconversion. Specifically, we tested the substrates cis-(1 S,2R)-indandiol and cis-
(1 R,2S)-indandiol. The trans-(1 R,2R)-indandiol was unavailable in quantities large enough for this
experiment. The results are shown in Table 3-4. We found that the NidC dehydrogenase could utilize cis-
(1 R,2S)-indandiol, but not cis-(1 S,2R)-indandiol. To investigate the stereospecificity further we tested
whether R- or S-styrene glycol could act as a substrate for the dehydrogenase in our enzyme assay.
Neither of these compounds acted as a substrate for the dehydrogenase (Table 3-4). The observation
that the NidC dehydrogenase can utilize cis-(1 R,2S)-indandiol and cis-(1 R,2S)-dihydro-naphthalenediol
suggests that NidC prefers its substrates in the cis-(1 R,2S) configuration.
Table 3-4: In vitro Dehydrogenase Enzyme Assay
Specific Activity
SQ1(pST 117) SQ1(pAPE12)
Substrate + --
Dehydrogenase Dehydrogenase
cis-(1R,2S)-indandiol 0.0037 ± 0.0016
cis-(1 S,2R)-indandiol -- -
cis-(1R,2S)-dihydro-naphthalenediol 0.0416 0.0125 -
R-styrene glycol -- Ndb
S-styrene glycol - Ndb
a -- = < 0.0001
b Nd, not determined
In vivo Dihydrodiol Breakdown
Since we had determined that the nidC gene encoded a dehydrogenase activity in vitro, we wanted to
investigate the in vivo characteristics of the dehydrogenase. This type of analysis would provide insights
into how the indene bioconversion pathway in Rhodococcus 124 might be manipulated. Therefore, we
developed an in vivo diol breakdown assay. This assay requires the addition of a given diol substrate
directly to the medium of a growing culture. Samples of the culture are then withdrawn over time and
analyzed by HPLC to determine whether the diol is still present in the medium or if it has been converted
to the dehydrogenated product.
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Figure 3-3: Dehydrogenase Enzyme Assay Standard Curves with cis-(1R,2S)-dihydro-
naphthalenediol
To assess the rate of the dehydrogenation reaction and the reproducibility of the assay, standard
curves using cis-(1R,2S)-dihydro-naphthalenediol as the substrate were developed. A) Initial rate
as a function of substrate concentration, B) Initial rate as a function of total protein concentration,
C) Lineweaver-Burke Plot.
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A series of R. erythropolis SQ1 derivative strains were analyzed for their ability to breakdown various
diols in vivo. These strains include R. erythropolis SQ1 transformed with: the original cosmid clone pR4
containing the dioxygenase subunits and the dehydrogenase; a cosmid subclone only containing the
dioxygenase subunits (pR4-1 0); the dehydrogenase expression plasmid (pST1 17); and the control
plasmid containing no inserted genes (pAPE12). The results are shown in Table 3-5. The in vivo results
mirror the in vitro analysis and confirm that the NidC dehydrogenase is stereospecific for the cis-(1 R,2S)-
diols. That is, in vivo the dehydrogenase can oxidize both cis-(1 R,2S)-indandiol and cis-(1 R,2S)-dihydro-
naphthalenediol, but not cis-(1S,2R)-indandiol. Furthermore, the dehydrogenase does not oxidize trans-
(1 R,2R)-indandiol. We observed that the cis-(1 R,2S)-dihydro-naphthalenediol was broken down in the
presence of the dehydrogenase. However, the breakdown product was undetectable by HPLC and may
have been further metabolized by the host strain R. erythropolis SQ1.
Table 3-5: In vivo Diol Breakdown Assay
Substrate SQJ(pAPE12) SQJ(pR4) SQJ(pR4-10) SQI(pSTJ17)
vector only cosmid clone dioxygenase only dehydrogenase
only
cis-(1R,2S)- - + - +
indandiol
cis-(1S,2R)- -- --
indandiol
trans-(1R,2R)- -- --
indandiol
cis-(1R,2S)- -- +a +a
dihydro-
naphthalenediol
a Substrate was consumed, product was undetectable by HPLC
Indene Bioconversion by Rhodococcus SQ1 derivative strains
Since the indene bioconversion pathway in Rhodococcus 124 is a complex network (Figure 3-1), we
wanted to begin to simplify the system in order to gain a better understanding of the pathway. One
approach is to construct a system in which the components of interest are added to the exclusion of
others. The naive host R. erythropolis SQ1 harboring the plasmids pR4 and pR4-1 0 represents one such
system. Based on the DNA sequence information (Treadway et al. 1999) we know that pR4 contains the
wild type dioxygenase genes and the dehydrogenase gene. We also know that pR4-1 0 contains the
dioxygenase genes but only the first 66 amino acids (out of 339) from the dehydrogenase. The truncated
dehydrogenase lacks the putative NAD' binding site and the Y-x-x-K putative active site motif (Jornvall et
al. 1995; Treadway et al. 1999). Consequently, the subclone pR4-10 is the genetic equivalent of a
dehydrogenase null mutation.
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We carried out indene bioconversions in batch fermentations with R. erythropolis SQ1 (pR4) and R.
erythropolis SQ1 (pR4-1 0) to see if there was a difference in the product formation profiles. These
fermentations were executed in the absence of silicon oil as a carrier for the indene. Instead, indene was
delivered in the vapor phase in closed vessels (a fermentor in this instance). The oil was removed
because Rhodococcus strains tend to grow exclusively in the oil phase and cling to the walls of the vessel;
R. erythropolis SQ1 is particularly adept at this. Other strains of Rhodococcus have demonstrated this
behavior as well (Neu 1996). The fermentation results are shown in Figure 3-4. No products were formed
in the R. erythropolis SQ1 control fermentation (data not shown). The major phenotypic difference
between R. erythropolis SQ1 (pR4) (Figure 3-4A) and R. erythropolis SQ1 (pR4-10) (Figure 3-4B) is the
lack of keto-OH-indan production by R. erythropolis SQ1 (pR4-1 0). R. erythropolis SQ1 (pR4-1 0) behaves
as expected for a nidC null mutant strain.
Deletion of the nidC Dehydrogenase Gene in Rhodococcus 124
Since the fermentation analysis suggested a clear phenotype for the nidC dehydrogenase deletion
mutant, we wanted to carry out a similar analysis of the dehydrogenase gene in the parent strain
Rhodococcus 124. We introduced the knock-out plasmid pST1 19 into Rhodococcus 124 by
transconjugation with Escherichia coli. Since this plasmid is unable to replicate in Rhodococcus, we
selected thiostrepton resistant colonies to identify strains in which the plasmid had undergone homologous
recombination to completely replace the nidC dehydrogenase gene with the tsr gene. As a control, E. coli
S17-1 (pST1 19) was mated to E. coli MM294-4, a nalidixic acid resistant derivative of E. coli MM294
(Bachmann 1987). Transconjugants were selected on 100 gg/mI ampicillin and 10 gg/ml nalidixic acid,
and grown at 370C overnight. Plasmid DNAs isolated from E. coli MM294-4 transconjugants were
analyzed by restriction enzyme digestion and agarose gel electrophoresis to confirm presence of the
plasmid pST1 19 (data not shown). Using this methodology we produced Rhodococcus 124AnidC, called
Rhodococcus ST-1 henceforth.
We confirmed the presence of the gene replacement and its location in the genome by PCR analysis
of genomic DNA. A schematic of this analysis using five sets of primers is depicted in Figure 3-5. Figure
3-6 shows the PCR results generated using genomic DNA isolated from the nidC deletion strain
Rhodococcus ST-1, Rhodococcus 124, and plasmid DNA controls. The DNA
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Figure 3-4: A model of the nidC knock-out: Indene Bioconversion of Rhodococcus SQ1(pR4)
and Rhodococcus SQ1(pR4-10)
Indene bioconversions were carried out in a batch fermentor to determine the product profile that
would result in a simulation of a nidC dehydrogenase deletion. A) Rhodococcus SQ1(pR4)
represent the wild-type dehydrogenase and B) Rhodococcus SQ1(pR4-10) represents the
dehydrogenase knock-out. The optical density of the fermentation cultures was similar. No trans-
indandiol is produced by Rhodococcus SQ1(pR4) or Rhodococcus SQ1(pR4-10). The
Rhodococcus SQ1 fermentation did not produce indene bioconversion product.
A S01 (pR4) Batch Fermentation
600
'/
,A
x
.17--- ---- K
Ux-
0 80 90 100 110 120 130 140
Hours
SQ1(pR4-10) Batch Fermentation
I I.S -
-w
+ -
--- nr-~' u n- -
Cis-diol
--- Keto
+-.Indenol
x - Indanone
100 120 140 160 180
Hours
E
C
02
500
400
300 L
200
100
o
I- Cis-diol
I- Keto
Indenol
- -Indanone
-100
7
B
600
E
.2
C.)
500
400
300
200
100
0F
80
83
I I
-100
fragments amplified from the genomic DNA of the knock-out strain Rhodococcus ST-1 were the sizes
predicted for a deletion mutant. Primer set one produced a few extra products with the cosmid template
pR4 that are presumably due to mis-priming of the primers on the template DNA. To further demonstrate
that the PCR products resembled the expected products they were digested with selected enzymes (data
not shown). All of the expected products digested predictably. None of the additional products from
primer set one with the pR4 template digested with the appropriate enzymes.
After confirming the presence of the gene deletion, wild-type Rhodococcus 124 and Rhodococcus ST-
1 strains were analyzed in a series of experiments to determine the effect of removing the nidC
dehydrogenase. The first set of experiments included uninduced and naphthalene-induced indene
bioconversions. The purpose of these experiments was to examine the overall phenotypic effect of
deleting the nidC dehydrogenase on the indene bioconversion profile. If this dehydrogenase is a major
contributor to the dehydrogenase activity in this system, removing this activity should have an effect on the
accumulation of cis-indandiol and the production of keto-OH-indan. The results from these experiments
are shown in Figures 3-7 and 3-8. There was no significant difference in the indene bioconversion product
profiles of Rhodococcus 124 (wild type) and Rhodococcus ST-1 either uninduced or naphthalene-induced.
PCR with Primer Sets
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Figure 3-5: Schematic of PCR Confirmation of Rhodococcus I24AnidC
Depiction of the PCR results expected using primers designed to confirm the presence and location
of the thiostrepton gene in Rhodococcus I24AnidC. Sequences of the primers can be found in
Table 3-3. The primer sets are as follows: primer set 1 DH-1 and SLT-8, primer set 2 DehKO-1
and inThio-1, primer set 3 DehKO-2 and inThio-2, primer set 4 inThio-2 and DH-4, primer set 5
inThio- 1 and DH- 1. For shorthand purposes on the diagram DehKO- 1 is KO-1, DehKO-2 is KO-
2, inThio- 1 is inT- 1, and inThio-2 is inT-2. The hatched box is the nidC gene and the stippled box
is the tsr gene.
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Figure 3-6: PCR Analysis of the nidC knock-out Rhodococcus ST-1 (next page)
PCR analysis was carried out genomic DNA and plasmid DNA to confirm the presence of the nidC
dehydrogenase knock-out in Rhodococcus 124. Lanes 1-5 are ST-I genomic DNA with primer sets
1,2,3,4,and 5 respectively. Lanes 6-10 are wild-type 124 genomic DNA with primer sets
1,2,3,4,and 5 respectively. Lanes 11-15 are pR4 plasmid DNA with primer sets 1,2,3,4,and 5
respectively. Lanes 16-20 are pST119 knock-out plasmid DNA with primer sets 1,2,3,4,and 5
respectively. The primer sets are as indicated in figure 3-5.
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The lack of a global phenotype alteration in the long term indene bioconversion experiments with
Rhodococcus ST-1 indicated that closer inspection was necessary. It is possible that the effect of the
dehydrogenase knock-out is negated in the long term by a second activity. Therefore, a difference may
be seen in the early stages of an indene bioconversion but not the late stages. Consequently, we
examined the induction profiles of the wildtype strain and the nidC null mutant in the first two hours of an
indene bioconversion. The results of this analysis are shown in Figure 3-9. There was no difference in the
naphthalene induction profiles of Rhodococcus 124 and Rhodococcus ST-1. The uninduced cells did not
display indene bioconversion in the two hour time frame examined (data not shown).
Since we had determined that the NidC diol dehydrogenase was stereospecific for cis-(1 R,2S)-
indandiol, an in vivo diol breakdown assay using cis-(1 R,2S)-indandiol as the substrate was conducted as
the third set of experiments. We found a significant rate difference in the oxidation of cis-(1 R,2S)-
indandiol between the wildtype and the null mutant strains (Figure 3-1 OA and 3-1 OB). The AnidC strain,
Rhodococcus ST-1, oxidizes the cis-(1 R,2S)-indandiol one third as rapidly as the wild-type strain.
Furthermore when Rhodococcus 124 and Rhodococcus ST-1 cells are pre-induced with naphthalene, the
rate of cis-(i R,2S)-indandiol breakdown is the same (Figure 3-11C and 3-11 B). However, when the rates
of cis-(1 R,2S)-indandiol breakdown in Rhodococcus ST-1 uninduced and naphthalene-induced cells are
compared, the there is a significant rate difference (Figure 3-11A and 3-11B). The uninduced
Rhodococcus ST-1 cells have a much slower rate of cis-(1 R,2S)-indandiol oxidation than the naphthalene-
induced cells. No rate differences were found when cis-(1 S,2R)-indandiol or cis-(1 R,2S)-dihydro-
naphthalenediol were used as substrates (data not shown).
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Figure 3-7: Indene bioconversion of Rhodococcus 124 and Rhodococcus ST-1
Indene bioconversions were conducted in batch fermentatiois in collaboration with K.
Yanagimachi. A) Rhodococcus ST-1, B) Rhodococcus 124, C) Optical Density (OD 600) of
cultures.
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Figure 3-8: Naphthalene-induced indene bioconversion by Rhodococcus 124 and
Rhodococcus ST-I
These experiments were conducted in screw capped flasks. There is some variability in these
experiments when conducted in a shake flask. The key feature of these results is the overall trend
and final relative positions of the indene metabolites produced. A) Rhodococcus ST-I
naphthalene-induced, B) Rhodococcus 124 naphthalene-induced, C) Optical Density (OD 600) of
cultures.
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Figure 3-9: Two hour induction analysis of Rhodococcus 124 and Rhodococcus ST-1
Cultures of Rhodococcus 124 and Rhodococcus ST-1 were grown in the presence and absence of
naphthalene. Indene was added at time zero and samples were taken at regular intervals to assess
indene bioconversion activity. A) Rhodococcus 124 naphthalene-induced, B) Rhodococcus ST-1
naphthalene-induced. The uninduced cultures (not shown) showed no indene bioconversion
activity in the first two hours.
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Figure 3-10: cis-(1R,2S)-indandiol Breakdown by Rhodococcus 124 and Rhodococcus ST-1
cis-(I R,2S)-indandiol was added directly to cultures of Rhodococcus ST-1 (Rhodococcus
I24AnidC) and Rhodococcus 124. The breakdown of the cis-(1R,2S)-indandiol and the production
of keto-OH-indan was monitored via HPLC analysis. A) Rhodococcus 124 cis-(1R,2S)-indandiol
breakdown, B) Rhodococcus ST-I cis-(1R,2S)-indandiol breakdown. CFU/ml was measured and
had no effect on the interpretation of the results when incorporated.
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Figure 3-11: Naphthalene-induced cis-(1R,2S)-indandiol Breakdown by Rhodococcus ST-1
Cultures were pre-grown in naphthalene for 24 hours prior to adding cis-(1R,2S)-indandiol. The
breakdown of the cis-(lR,2S)-indandiol and the production of keto-OH-indan was monitored via
HPLC analysis. All graphs are normalized to CFU/ml since culture conditions were different in
the presence versus the absence of naphthalene. A) uninduced Rhodococcus ST-i cis-(1R,2S)-
indandiol breakdown, B) naphthalene-induced Rhodococcus ST-i cis-(1R,2S)-indandiol
breakdown, C) naphthalene-induced Rhodococcus 124 cis-(1R,2S)-indandiol breakdown.
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Discussion
In our earlier work we identified the nidC gene and showed it was homologous to a variety of diol
dehydrogenases (Chapter Two)(Treadway et al. 1999). In this work we have demonstrated using both
biochemical and genetic analysis that the nidC gene encodes a functional diol dehydrogenase. In vivo
characterization of the nidC gene expressed in a heterologous host demonstrated that the nidC gene
product could oxidize dihydrodiol compounds. Furthermore, the in vitro enzyme assay results mirror the in
vivo results. This supports the notion that NidC is a diol dehydrogenase.
In our analysis of the NidC dehydrogenase we found that it has two levels of selectivity. First as
demonstrated in the in vivo analysis, the dehydrogenase discriminates between cis and trans forms of
indandiol. Other diol dehydrogenases have been shown to be substrate selective in this way (Fong et al.
1996; Patel and Gibson 1974; Rogers and Gibson 1977). Second, the NidC dehydrogenase is
stereospecific for a certain cis-indandiol enantiomer. In two separate assays the dehydrogenase could
utilize cis-(1 R,2S)-indandiol as a substrate, but not cis-(1 S,2R)-indandiol. This degree of stereospecificity
has been demonstrated in Pseudomonas and other organisms (Allen et al. 1995; Buckland et al. 1999;
Eaton et al. 1996; Jeffrey et al. 1975; Sato et al. 1994). Other diol dehydrogenases have been shown to
have a preference for one enantiomer over the other, but are still able to oxidize both forms (Burczynski et
al. 1998; Geerlof et al. 1994). Our results also suggest that this specificity may be determined by the
presence of the -OH group at the 2 position since neither enantiomer of styrene glycol could be utilized as
a substrate by the NidC dehydrogenase. It is interesting to note that the NidC dehydrogenase is specific
for the cis-indandiol that is produced by the NidAB dioxygenase that is genetically associated with the
dehydrogenase. This suggests the possibility that each oxygenase system in Rhodococcus 124 (Figure 3-
1) has a coordinating stereospecific dehydrogenase activity. Based on the stereospecificity of the NidC
dehydrogenase, we conclude that there is at least one more diol dehydrogenase activity in this strain.
To better understand the indene bioconversion pathway in Rhodococcus 124 we simplified the system
by removing the dehydrogenase activity. We did this in two ways: by analyzing the nidABC system in
isolation and by studying Rhodococcus 124 lacking nidC. The first method utilized the heterologous host
R. erythropolis SQ1, a related species unable to metabolize indene. We constructed R. erythropolis SQ1
derivative strains carrying the dioxygenase and dehydrogenase (nidABC) or carrying the dioxygenase only
(nidAB). In this system removing the nidC dehydrogenase prevented the oxidation of cis-(1 R,2S)-
indandiol in an indene bioconversion. This result was further confirmed by the in vivo diol breakdown
assay. When we applied the same analysis to Rhodococcus 124 and Rhodococcus ST-1 (Rhodococcus
124AnidC) we found a more complicated scenario. We observed a reduction in the amount of cis-(1 R,2S)-
indandiol dehydrogenation rather than abolishment of the activity in uninduced cells. Consequently, it
appears that the nidC dehydrogenase is expressed at low levels without inducing the system with indene
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or naphthalene. Moreover, our results show that there is at least one other diol dehydrogenase in
Rhodococcus 124 capable of utilizing cis-(1 R,2S)-indandiol as a substrate. When Rhodococcus ST-1 is
pre-induced with naphthalene the rate of cis-(1 R,2S)-indandiol oxidation is the same as in the
naphthalene-induced wild-type strain Rhodococcus 124. This suggests that this additional dehydrogenase
activity may be naphthalene-inducible. Based on our proposed pathway (Figure 3-1), this activity could be
the dehydrogenase associated with the naphthalene-inducible monooxygenase. Therefore, it is possible
that the other dehydrogenase(s) in the Rhodococcus 124 indene bioconversion pathway is(are) not
stereospecific. However, it is also possible that all of the keto-OH-indan is derived from the cis-(1R,2S)-
indandiol. We are in the process of investigating the effects of nidC overexpression in Rhodococcus 124
especially in terms of the ratio of cis-(1 R,2S)-indandiol to cis-(1 S,2R)-indandiol.
Rhodococcus 124 employs three oxygenase systems and at least two diol dehydrogenases in the
conversion of indene to keto-OH-indan. We have shown that one of these dehydrogenases is
stereospecific for one of the indandiols produced in this network, specifically cis-(1 R,2S)-indandiol. As we
begin to unravel the indene bioconversion pathway in Rhodococcus 124 we find increasing layers of
complexity. We are in the process of isolating the genes encoding the enzymes in the other branches of
this pathway so we may further understand the indene bioconversion network. As we continue to study
bacteria capable of stereospecific bioconversions we hope to develop a controllable process for the
production of chiral compounds. At the same time we will gain a fundamental understanding of how
Rhodococcus, and other organisms like it, metabolize aromatic hydrocarbons.
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Chapter Four: Conclusion
Summary
Rhodococcus strain 124 was recently isolated from soil contaminated with aromatic hydrocarbons. As
a newly isolated strain, Rhodococcus strain 124 was genetically uncharacterized. The diverse nature of
the Rhodococcus genus requires the of testing of different available genetic tools to determine if they are
useful for analysis of the strain in question. Consequently, multiple genetic tools were analyzed and
developed to facilitate analysis of Rhodococcus strain 124. In work not explicitly described here,
numerous plasmids were obtained from other researchers to find suitable vectors to use in a variety of
genetic analyses. One of these plasmids was used in the construction of the multi-host cosmid vector
pRhodoCOS described in Chapter Two. In addition, numerous molecular biology protocols for plasmid
isolation, genomic DNA isolation, transformation, and conjugation were examined for their effectiveness in
Rhodococcus strain 124. Many of these molecular biology/microbiology techniques required considerable
optimization whereas others had to be developed de novo. Without these tools this project would never
have been possible.
Rhodococcus strain 124 is capable of utilizing aromatic hydrocarbons as carbon sources, specifically
naphthalene and toluene. The bioconversion of indene to three enantiomers of indandiol, keto-OH-indan,
1 -indenol and 1 -indanone is an interesting feature of this strain. Two of the indandiols produced can be
used as a precursor for the HIV-1 protease inhibitor indinavir (Crixivan TM) (see Chapter One). Cloning of
the different genes encoding the enzymes responsible for this bioconversion has led to an enhanced
understanding of the indene bioconversion network in Rhodococcus strain 124. A functional screen
identified genes encoding a ring-hydroxylating dioxygenase system (nidAB) that catalyzes the conversion
of indene to cis-(1 R,2S)-indandiol. Based on the induction studies of Chartrain and colleagues (Chartrain
et al. 1998), the cis-(1 R,2S)-indandiol is produced from indene by a naphthalene-inducible dioxygenase.
Consequently, the NidAB dioxygenase could be naphthalene inducible; however, this has never been
demonstrated experimentally. Analysis of naphthalene-induced indene bioconversions in R. erythropolis
SQ1 (pR4), a strain expressing the nid genes on a plasmid, could possibly answer this question. If the
appropriate regulatory factors are present on the pR4 clone there could be a dramatic increase in the
production of cis-(1 R,2S)-indandiol in naphthalene-induced cells as compared to uninduced cells. Another
way to address the issue of naphthalene inducibility would be to integrate a reporter gene, such as lacZ,
into the genome replacing the dioxygenase and monitor s-galactosidase activity when the cells are
induced with naphthalene.
Researchers have demonstrated that electron transport proteins are required for dioxygenase activity
(Ensley and Gibson 1983; Haigler and Gibson 1990a; Haigler and Gibson 1990b; Subramanian et al.
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1985). Sequence analysis of the nidAB dioxygenase system indicated that there are no identifiable genes
encoding the electron transport proteins genetically associated with the dioxygenase subunits. As
discussed in Chapter Two, there may be novel genes for the electron transport or they may be borrowed
from the host strain used in the experiments. Alternatively, NidAB may represent a new class of
dioxygenase system not previously described. An indene bioconversion using a strain containing a
plasmid expressing just the dioxygenase subunits from a known promoter could experimentally address
this. If the construct promotes the bioconversion of indene, then the dioxygenase subunits are either
borrowing the electron transport proteins or they are not required. The dioxygenase subunits may be
unable to promote indene bioconversion. Therefore the smallest functional unit of the subclone pR4-1 0,
which is known to express the dioxygenase subunits, could be determined via nested deletion analysis.
There are five kb of DNA upstream of the dioxygenase subunits in this subclone that could contain novel
genes for the reductase and ferredoxin electron transport proteins. Unfortunately, the possibility of
borrowing electron transport proteins can never really be fully eliminated regardless of the host strain
used.
In addition to genes encoding dioxygenase subunits, a diol dehydrogenase (nidC) was also identified.
The gene encoding this enzyme is located next to the dioxygenase small subunit gene. This enzyme is
responsible for the conversion of the cis-(1 R,2S)-indandiol to keto-OH-indan, as demonstrated in indene
bioconversion experiments. Further analysis of the diol dehydrogenase, described in Chapter Three,
determined that the enzyme is stereospecific for cis-(1 R,2S)-indandiol produced by the nidAB
dioxygenase system. It is not capable of using any other indandiol produced during a Rhodococcus strain
124 indene bioconversion as a substrate. The nidC null mutant strain is still capable of oxidizing cis-
(1 R,2S)-indandiol, although at a reduced rate. The implications of these findings are discussed below.
The nidABC genes appear to be a functional unit, although it remains to be determined if they are part
of a true operon. Often operons containing genes encoding aromatic hydrocarbon metabolism pathways
are located on plasmids. Both the naphthalene and toluene metabolism genes in Pseudomonas putida
are located on plasmids (Williams and Worsey 1976; Yen and Gunsalus 1982). Some of these plasmids
have been found to be linear (Dabrock et al. 1994; Masai et al. 1997), and/or transmissible (Dabrock et al.
1994; Nakazawa and Yokota 1977; Shields et al. 1995). Genome analysis of Rhodococcus strain 124
determined that the genome is approximately 3.0 Mb and contains a large plasmid (p124) that is about 340
kb. It would be interesting to determine if the nidABC genes are located on p124, and if the plasmid p124 is
linear or transmissible. Rhodococcus strain 124 DNA separated by pulse field gel electrophoresis could be
analyzed via Southern blotting could determine if the nid genes are chromosomally or plasmid encoded.
To determine the structure of p124, PFG samples of could be treated with exonuclease Ill and
topoisomerase 1. Exonuclease I treated DNA should exhibit a mobility shift or smearing due to digestion
of the linear DNA. DNA samples treated with topoisomerase I would exhibit a mobility shift if the plasmid
is circular due to nicking of the plasmid DNA. Nicking the DNA relaxes the supercoils of the plasmid.
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Alternatively, the gene location and transmissibility of the plasmid could be determined simultaneously. If
the nid genes are located on the plasmid it is possible that transfer of the plasmid to a naive host could
confer the ability to grow on aromatic carbon sources such as toluene or naphthalene. PFG analysis of
the new strain would demonstrate transmission of the plasmid and genomic DNA analysis using homology
based methods or PCR would demonstrate the presence of the nid genes. This analysis could be
extremely useful as it could lead to the identification of other genes involved in the indene bioconversion
pathway.
The natural substrate of the Nid enzymes is not known. We hypothesize that naphthalene may be a
natural substrate since it can be used as a carbon source by the strain. However, we have never tested if
naphthalene can act as a substrate for the NidAB dioxygenase. We do know that a naphthalene
derivative, cis-(1 R,2S)-dihydro-naphthalenediol, can act as a substrate for the NidC dehydrogenase. It
would be interesting to see what compounds would be produced in the dioxygenase and dehydrogenation
reactions when naphthalene is used as a substrate. A possible naphthalene degradation pathway is
shown in Figure 4-1. One experiment to address this would be to use R. erythropolis SQ1 (pR4), R.
erythropolis SQ1 (pR4-1 0), and R. erythropolis SQ1 in a naphthalene bioconversion experiment. The
products produced could be isolated via HPLC separation and analyzed by NMR to determine their
structures. The results expected from this experiment are described in Table 4-1 below. In Chapter Two
we hypothesized that the NidAB dioxygenase is a naphthalene-type dioxygenase, the conversion of
naphthalene to 1,2-dihydro-naphthalenediol could support that notion. Naphthalene utilization could be
examined in Rhodococcus strain 124 and Rhodococcus ST-1 as well. Due to the presence of multiple
oxygenase pathways, two of which appear to be naphthalene-inducible, it is likely that the bioconversion of
naphthalene will produce multiple enantiomers of 1,2-dihydro-naphthalenediol as well as other
compounds. Analysis of the naphthalene breakdown products in these two systems could provide insights
into the indene bioconversion pathway and the stereospecificity of the enzymes involved.
Ring-hydroxylating dioxygenases can oxygenate in a stereospecific manner that may be related to the
substrate. The NidAB dioxygenase stereospecifically oxygenates indene to cis-(1 R,2S)-indandiol and 1-
indenol. Other dioxygenase have been shown to stereospecifically oxygenate indene (Allen et al. 1995;
Allen et al. 1997; Gibson et al. 1995; Wackett et al. 1988). Interestingly, the naphthalene dioxygenase
(NDO) from Pseudomonas putida can oxygenate indene to cis-(1 R,2S)-indandiol and
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Figure 4-1: Proposed pathway of naphthalene oxygenation by NidABC System
A possible pathway for naphthalene oxygenation by the Nid enzymes is shown above. The
pathway resembles a portion of the upper pathway of naphthalene degradation from Pseudomonas
putida.
Table 4-1: Naphthalene as a substrate of NidABC enzymes
Strain Enzyme Content Compounds Expected from
___ 
___ 
_ 
Naphthalene
R. erythropolis SQ1 none none
R. erythropolis SQ1 (pR4) dioxygenase (large and small cis-1,2-dihydro-naphthalenediol
subunits)
dehydrogenase 1,2-naphthalenediol
R. erythropolis SQ1 (pR4-1 0) dioxygenase (large and small cis- 1,2-dihydro-naphthalenediol
.........._ _ subunits)
1 S-indenol (Resnick et al. 1996). Based on sequence alignments, the NidAB a subunit is 30 % similar to
the a subunit of the NDO from P. putida. Further comparison of the two dioxygenases based on data from
the crystal structure of the NDO (Kauppi et al. 1998), suggests that NDO and NidA (the large subunit of
the NidAB dioxygenase) may have a similar active site/mononuclear iron binding site. The active site
residues of NDO have been suggested to be His 208, His 213, and Asp 362. The residue Asp 205 is also
required for activity and likely is responsible for electron transfer (Parales et al. 1999). The NidA
dioxygenase subunit aligns with the NDO and the strongest regions of identity are in the Reiske iron-sulfur
center and the mononuclear iron binding/active site. In NidA the iron coordinating residues are likely His
216, His 221, and Asp 372. The Asp residue is spaced slightly differently, there are two extra residues
between the His 221 and Asp 372. There is also a corresponding Asp residue, Asp 213, to the electron
transfer Asp residue of NDO. It is unclear how the active sites of these enzymes play a role in substrate
specificity.
100
Naphthalene
New Models for Indene Bioconversion in 124
A new model for the indene bioconversion pathway is shown in Figure 4-2 based on all of the data
described in this work. Rhodococcus strain 124 contains one dioxygenase system (NidAB) that is specific
for the production of cis-(1 R,2S)-indandiol. This dioxygenase also is responsible, at least partially, for
producing 1 -indenol and 1 -indandone in an indene bioconversion. Coordinately expressed with the
dioxygenase system is a diol dehydrogenase called NidC. The dehydrogenase oxidizes the cis-(1 R,2S)-
indandiol produced in an indene bioconversion, and only the cis-(1 R,2S)-indandiol, to keto-OH-indan in
this pathway. No other indandiol in this system can act as a substrate for the NidC dehydrogenase.
Analysis of the nidC diol dehydrogenase null mutant strain, Rhodococcus ST-1, uncovered a second diol
dehydrogenase activity in this strain that uses cis-(1 R,2S)-indandiol as a substrate. This activity appears
to be induced by naphthalene; consequently this dehydrogenase could be a dehydrogenase that is
coordinately expressed with the naphthalene inducible monooxygenase activity. These data suggest that
the indene bioconversion network is complex, and has multiple oxygenases and multiple dehydrogenases.
OH
.. OH NAD
Toluene cis-(1S,2R)-Indandiol NADH
Dioxygenase Dehydrogenase
OH
SNaphthalene ~. 
N N.D
____ _1__ __ OH
Monooxygenase Dehydrogenase
Indene Indan Oxide trans-(1R,2R)-Indandiol
nidAB NADH
Naphthalene NAD
Dioxygenase OH dC ehydro ase
H OH 2d R OH
cis-(1R,2S)-Indandiol 2nd I I R,2S)-lrdandiol keto-OH-dehydrogenaseinn
1-Indenol indan
1-Indanone
Figure 4-2: Modified Pathway for Indene Bioconversion Pathway in Rhodococcus 124
Above is the new proposed pathway for indene bioconversion including data from the nidC
dehydrogenase knock-out strain, Rhodococcus ST-1. The analysis of the strain suggests that there
is a second dehydrogenase capable of utilizing cis-( IR,2S)-indandiol as a substrate in
Rhodococcus strain 124.
Work by others in the laboratory not discussed in this thesis also indicates that a greater degree of
complexity in the indene bioconversion pathway than previously believed. Some of this data is discussed
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below and a second model for the indene bioconversion pathway is proposed. The comprehensive model
combining the data described in this thesis with data from other reasearch is shown in Figure 4-3. Two
experiments were conducted that provided insights into the indene bioconversion pathway. Both
experiments were designed to investigate the monooxygenation reaction and its components.
Rhodococcus KY-1, a Rhodococcus strain 124 derivative strain that has an altered indene bioconversion
profile, was used in these experiments. The first experiment was a biochemical analysis indan oxide and
its breakdown during an indene bioconversion. The second experiment was a radiolabeled substrate
utilization experiment using the trans-(1 R,2R)-indandiol. The biochemical analysis of indan oxide
demonstrated that there is a spontaneous breakdown of this intermediate in a 1:1 fashion to produce
trans-(1 R,2R)-indandiol and cis-(1 S,2R)-indandiol. This was shown by monitoring the breakdown of
chemically synthesized indan oxide in cleared cell lysates of Rhodococcus KY-1. Even when the cells
were pre-induced with naphthalene or toluene the indan oxide still resolved into trans-(1 R,2R)-indandiol
and cis-(1 S,2R)-indandiol in a 1:1 ratio. Consequently the indan oxide could predominantly be a single
enantiomer, specifically R-indan oxide (A. Dexter, unpublished results). In order to account for the
naphthalene induction studies of Chartrain and colleagues, there could be a naphthalene inducible
epoxide hydrolase (or equivalent activity) in Rhodococcus strain 124 that is not in the derivative strain.
Such an enzymatic activity could account for the increased production of the trans-(1 R,2R)-indandiol over
cis-(1 S,2R)-indandiol in a naphthalene-induced indene bioconversion. However, it seems unlikely that
such a hydrolase exists in this system even though the identity of the modification of Rhodococcus strain
124 that created Rhodococcus KY-1 is unknown. A more plausible explanation, that is depicted in the
model Figure 4-3, is that there is a naphthalene-inducible dehydrogenase that can oxidize the cis-(1 S,2R)-
indandiol but not the trans-(1 R,2R)-indandiol. The substrate utilization experiments using radiolabeled
trans-(1 R,2R)-indandiol provided some information towards this hypothesis. From these experiments it is
believed that the trans-(1 R,2R)-indandiol is not oxidized very rapidly, or at all, by a dehydrogenase in
Rhodococcus strain 124 (K. Yanagimachi, unpublished results). This observation can also explain the
overwhelming accumulation of trans-(1R,2R)-indandiol in long term (100 + hour) indene bioconversion
fermentations of Rhodococcus strain 124 (Chartrain et al. 1998).
Both of these models are intriguing and suggest further experiments. Each of the models predict the
presence of a second dehydrogenase. Experimental data presented in Chapter Three supports the first
model suggesting the presence of a naphthalene-inducible dehydrogenase that can oxidize cis-(1 R,2S)-
indandiol . The second model also proposes the presence of a naphthalene-inducible dioxygenase, but
this dehydrogenase can oxidize cis-(1 S,2R)-indandiol. It is possible that these dehydrogenases may be
one in the same, that is, a non-stereospecific dehydrogenase. Most dehydrogenases identified to date do
not exhibit absolute stereospecificity. Instead the enzymes display preferences for one enantiomer as
determined by rate differences in substrate utilization. To determine if there is naphthalene-inducible
dehydrogenase that can oxidize cis-(1S,2R)-indandiol, radiolabeled substrate experiments could be
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carried out using Rhodococcus strain 124 or Rhodococcus ST-1, either strain should produce the same
results. The radiolabeled substrate improves quantitative analysis and reduces the quantity of substrate
needed for the experiment. Using cells induced with naphthalene or uninduced, the breakdown
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Dioxygenase
Indene
nidAB
Naphthalene-
inducible
Dioxygenase
H
1-Indenol
I-Indanone
0
Indan Oxide
1:1 S
brea
inda
OH
d1OH
cis-(1S,2R)-Indandiol
OH
csr2 
OH
cis-(IR,2S)-Indandiol
OH
-# OH
trans-(lR,2R)-Indandiol
pontaneous
kdown of
n oxide
Naphthalene-inducible
Dehydrogenase
Figure 4-3: Comprehensive Model for Indene Bioconversion in Rhodococcus strain 124
This model is based on unpublished data from members of the Sinskey Laboratory and the
Stephanopoulos Laboratory. In an indene bioconversion the indan-oxide appears to break down in
a 1:1 ratio into trans-( 1R,2R)-indandiol and cis-(1S,2R)-indandiol, suggesting a spontaneous
reaction. Radiolabeled trans-(1R,2R)-indandiol does not rapidly breakdown during an indene
bioconversion.
of radiolabeled cis-(1S,2R)-indandiol could be monitored by HPLC. The rate of cis-(1S,2R)-indandiol
breakdown should be faster in the naphthalene-induced cells if there is a naphthalene-inducible
dehydrogenase capable of using cis-(1S,2R)-indandiol as a substrate. Using information from the
naphthalene bioconversion discussed above it may be possible to design a functional assay for the
production of colored naphthalene derivatives, such as 1,2-naphthalenediols, to screen for this second
dehydrogenase using Rhodococcus ST-1 as the host strain.
Modifying the Indene Bioconversion Network
It is essential to consider two methodologies commonly used to modify a pathway when investigating
the pharmaceutical application of this indene bioconversion system (Figure 4-4). One method is to
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remove all competing and side reactions from the system. Genetically this can be done by creating null
mutants using homologous recombination or amplifying the expression of other genes. This requires the
cloning of most, if not all, of the genes involved in the system. The second method is to introduce the
appropriate genes into a heterologous host to reconstitute the portions of the pathway necessary for the
application. This method requires the cloning of the genes encoding the enzymes that produce the
desired product. A priorithere is no reason to favor either approach.
Rhodococcus strain 124 with different
genes knocked-out by homologous
recombination. Reguires the
identification of multiple genes, if not
CC all.
Rhodococcus strain 124
OH
Heterologous host (e.g. R. erythropolis
SQl) expressing one small set of genes
to produce the desired compounds
Figure 4-4: Modifying the Indene Bioconversion Pathway
There are two ways to optimize a pathway, by removing activities from the native system (upper
right) or by expressing the desired activities in a naive host (bottom right). Depending on the
complexity of the system one methodology could be more direct than the other.
The indene bioconversion pathway can be modified by either methodology, the disruption method or
the reconstitution method. The indene network has multiple redundant systems including oxygenases and
dehydrogenases and the substrate range of these enzymes is unknown at this time. Thus modifying the
indene bioconversion pathway via the removal method may be difficult because multiple genes need to be
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cloned in order to remove their activities from the system. As seen with the nidC dehydrogenase null
mutant, removing an activity does not always result in the predicted alteration. However, given the tools
and genes identified there are two ways to modify the indene bioconversion pathway that may yield a
useful modified strain. The first modification would be to remove the genes encoding the nidAB
dioxygenase. This dioxygenase is responsible for production of at least some of the cis-(1 R,2S)-indandiol
in Rhodococcus strain 124. Removing the nidAB genes might eliminate production of the cis-(1 R,2S)-
indandiol. Another way to reduce or remove the unwanted indandiol enantiomer would be to overexpress
the nidC diol dehydrogenase since it is specific for the cis-(1 R,2S)-indandiol. These methods alone, or
possibly combined, could produce a modified version of Rhodococcus strain 124 that produces only the
other two indandiols.
Reconstruction of part of the indene bioconversion pathway can result in a simplified system that may
be useful for the production of an indandiol precursor molecule. Using the cosmid clone pR4 and the
subclone pR4-1 0 described in Chapter Three, we demonstrated that the reconstruction methodology is
viable for introducing a small portion of the indene pathway into a naive host. For a summary of these
simplified indene bioconversions see Figure 4-5. Due to the complexity of the indene bioconversion
pathway and the potential for hidden activities, reconstitution may be a better route to an engineered strain
in this case. Reconstruction requires the cloning of the other oxygenase systems in Rhodococcus strain
124. This could be attained in a variety of ways. Using the sequences available in the public databases
and the sequence of the dioxygenase NidAB, homology based methods could be used to identify new
genes by screening the cosmid library. The clustering of genes (e.g. the dioxygenase and the
dehydrogenase) permits the use of both the dioxygenase and dehydrogenase as probes.
In addition to homology based methods, other functional screens could be developed and used to
isolate genes encoding parts of the indene bioconversion pathway. For instance, mutagenized cells of
Rhodococcus strain 124 or Rhodococcus ST-1 could be grown in the presence of naphthalene or toluene,
and screened for mutants specifically in the oxygenase systems using nitro blue tetrazolium (NBT)/2,3,5-
triphenyl-2H-tetrazloium chloride (TTC) system described in the introduction. Mutants in the
oxygenase system should be different from the wild-type cells grown under the same conditions.
Furthermore, if the naphthalene breakdown profile was determined it may be possible to use a
naphthalene derivative (many of which are colored) in a functional screen to clone other genes. Similar
analysis could be conducted with toluene as the substrate. The genes would ultimately be cloned by
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Figure 4-5: Summary of indene bioconversions
There are three strains that were examined for their ability to bioconvert indene. This diagram
shows a summary of those bioconversions. A). R. erythropolis SQl(pR4), the original cosmid
clone, B) R. erythropolis SQ1(pR4-10), a subclone of pR4-10, C) Rhodococcus strain 124, a
modified model.
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complementation using the currently available cosmid library. To specifically target the monooxygenase
activity it may be possibly to identify a substrate that can be converted to a colored epoxide that could be
visualized. The identification of genes encoding the other oxygenase systems is essential for future
modifications to Rhodococcus strain 124.
Given the model proposed in Figure 4-3, it may be imperative to clone the second dehydrogenase
activity in order to reconstruct a strain for the production of an indandiol precursor. Although either trans-
(1 R,2R)-indandiol or cis-(1 S,2R)-indandiol can be used as a precursor, a mixture of the two would need to
be separated into its constituent parts. Consequently, it would be ideal to reconstruct a strain that
produces only one of the appropriate indandiols. If the indan oxide is spontaneously breaking down into
these two indandiols then a dehydrogenase may be employed to remove one enantiomer. We believe the
strain Rhodococcus strain 124 already contains a useful dehydrogenase to accomplish this (see above).
As previously discussed there a variety of ways to clone other dehydrogenases.
Conclusion
An increasing amount of research is being directed at the analysis of Rhodococcus species and their
diverse metabolic capabilities. Rhodococci have the potential to play a major role in bioremediation and
pharmaceutical synthesis. Researchers have only begun to realize the full potential of this species. Even
though Rhodococci are diverse and not genetically well characterized, it is possible to genetically
manipulate them. As more strains are characterized genetic analysis should become easier as
commonalties between strains are determined.
The genetic analysis of Rhodococcus strain 124 has been a rewarding research experience. Basic
microbiology, molecular biology and biochemistry were combined towards the analysis of the strain and its
ability to carry out the bioconversion of indene. The Rhodococcus strain 124 indene bioconversion
pathway is a complex network. From the analyses presented in this work we have shown it is possible to
develop a framework in which to analyze newly identified strains of bacteria and their unique attributes.
We established a model pathway for the bioconversion of indene and developed methods to identify
genes that encode the enzymes in that pathway. In order to analyze the genes and the enzymes encoded
by them, we developed genetic tools to modify the strain and enzymatic assays to investigate the
capabilities of the enzymes. The model for the indene bioconversion pathway was modified based on the
genetic and enzymatic analysis conducted using these tools, providing new insights for future analysis of
the system. The framework, the genetic tools and the biochemical tools/assays developed in this work will
be invaluable for continuing investigations of the indene bioconversion pathway in Rhodococcus strain 124
and the development of a genetically engineered strain to produce a precursor for an important
therapeutic, the HIV-1 protease inhibitor CrixivanTM.
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Appendix A: Construction of a nidAB Null Mutant
In order to analyze the indene bioconversion network construction of a null mutant of the nidAB
dioxygenase was attempted. A knock-out construct, pST1 24, was made. Most of the nidAB open reading
frames was replaced with the gene encoding spectinomycin antibiotic resistance, aadA, from the omega
interposon (Prentki et al. 1991). This plasmid has the RP4 mobility element and this construct can be
mobilized from E. cofi S1 7-1 to Rhodococcus strain 124. A standard filter mating was conducted to
introduce the plasmid into Rhodococcus strain 124. The protocol is described in Chapter Three.
Transconjugants were selected on LB plates supplemented with spectinomycin (200 pg/ml) and nalidixic
acid (10 gg/ml). The plates were incubated at 300C and colonies appeared after about one week. This
was about the same amount of time needed in other conjugation experiments with Rhodococcus strain
124. Approximately 15 candidate strains were obtained from several mating experiments.
Genomic DNA of the candidate strains was analyzed by PCR and by southern blotting. The control
PCR reactions in the PCR analysis were unreliable. Consequently PCR analysis was not used to
determine if any of the candidate strains were nidAB null mutants. The primers may not have been
optimal. The southern blot analysis was more successful, but required optimization. The best southern
blot results were obtained when the DNA was transferred in 20X SSC rather than in NaOH. The
hybridization temperature used in these experiments was 420C. Recent work has suggested that the
hybridization can be further improved if incubated at 650C (A. Dexter, unpublished results). A variety of
different probes including a portion of the nidA gene, the nidC gene, and the aadA gene, were used in this
analysis. None the spectinomycin resistant strains represented a deletion of the nidAB genes.
Furthermore, none of these strains carried a gene homologous to the aadA gene. This suggests that
Rhodococcus strain 124 can become resistant to spectinomycin relatively easily, although a rate was never
calculated.
In order to repeat this experiment it would be necessary to reconstruct the knock-out construct,
replacing the aadA spec gene with a different antibiotic marker. The thiostrepton (tsr) gene is the
antibiotic marker recommended as it was used successfully in the deletion of the nidC gene. I originally
chose the spec gene as a marker in case a double mutant lacking the dioxygenase and the
dehydrogenase, a AnidABC strain, was needed. Given the fact that nidABC are probably in an operon, it
may be unnecessary to prepare a double mutant, as disruption of the dioxygenase subunits may result in
the disruption of the dehydrogenase gene as well. Hence, using the tsr should not be a problem for
constructing a null mutant of nidAB.
Prentki P, Binda A, Epstein A (1991) Plasmid vectors for selecting IS1 -promoted deletions in cloned
DNA:Sequence analysis of the Omega interposon. Gene 103:17-23
110
Appendix B: Diol Dehydrogenase Enzyme Assay - The Numbers
Although in crude lysates the activity rates are not very meaningful for comparison to other
dehydrogenases, these numbers may be helpful toward the purification of this enzyme. Below are tables
with the rates in AU/min as derived from the spectrophotometer. These rates were determined by using
the initial slope of the reaction. Total reaction time was 600 sec. However, the reaction was complete
within the first 200 seconds. The enzyme assay conditions are described in Chapter Three.
The optical density of the culture prior to lysate production significantly reduces the enzyme activity.
Cultures with higher OD600 (4.0-5.0) generally had less activity than those with an OD 60 of 2.0-3.5. This
was deceiving at first because protein concentrations of the higher OD600 cultures were similar to the
protein concentrations of lysates derived from cultures with a lower optical density. It is possible that the
higher OD is the consequence of dead cells, which can contribute to the protein concentration, but that the
dehydrogenase enzyme is unstable under these conditions.
All enzyme assays in the table were conducted with cis-(l R,2S)-dihydro-naphthalenediol as the
substrate. Rates are determined immediately after lysate production. The lysate still contains activity the
next day, but the rate is reduced by about half.
R. erythropolis
SQ1 (pST1 17) Lysate OD600  Total Protein (p g/ul) Rate (AU/min)
Number Date
1 6-8-98 2.76 30.58 0.168
2 6-8-98 2.52 34.36 0.125
3 6-15-98 2.6 16.02 0.304
4 6-15-98 2.18 11.95 0.298
5 6-15-98 2.18 19.29 0.235
0.273
0.268
6 6-18-98 2.48 12.9 0.229
7 6-18-98 2.88 14.9 0.199
8 9-14-98 2.28 8.9 0.732
9 9-14-98 2.48 11.3 0.298
10 9-14-98 3.34 10.9 0.333
11 9-23-98 4.68 9.97 0.089
12 9-23-98 3.7 6.22 0.062
13 9-23-98 4.94 10.66 0.112
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Appendix C: Indandiol Oxidation - Another Way to Present the Data
The analysis of indandiol oxidation by R. erythropolis SQ1 derivative strains, Rhodococcus 124, and
Rhodococcus ST-1 can be presented in tabular fashion. Those tables are presented below.
Indandiol Oxidation of Rhodococcus 124 and Rhodococcus ST-1 (Rhodococcus 124AnidC)
See Chapter Three
cis-(1 R,2S)-indandiol cis-(1 S,2R)-indandiol
At 0 hrs At 24 hrs At 0 hrs At 24 hrs
Strain [initial] [cis] [keto] [initial] [cis] [keto]
mg/L mg/L mg/I mg/L mg/L mg/l
Rhodococcus
124 AnidC
18.70 12.90 2.35 53.36 50.04 5.48
16.20 13.60 2.80 j 36.73 28.19 3.74
40.65 29.30 6.10
_____ I . Average
Rhodococcus 43.90 6.10 23.90 43.20 37.60 4.93
124 19.12 5.01 9.60 32.73 31.87 5.14
15.31 453 7.38
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In vivo Indandiol Oxidation
See Chapter Three for method and an alternative presentation of the data.
cis-(1 R,2S)-indandiol cis-(1 S,2R)-indandiol trans-(1 R2R)-indandiol
Strains Genes at 0 hrs at 24 hrs at 0 hrs at 24 hrs at 0 hrs at 24 hrs
Expressed [initial] [cis] [keto] [initial] [cis] [keto] [initial] [cis] [keto]
I I_ mg/L mg/L mg/l mg/L mg/L mg/l mg/L mg/L mg/l
R. erythropolis
SQ1 (pAPE12)
none 6.99
7.69
8.10
7.09
0.00 42.57 40.97 0.00 24.20
31.80
25.20
31.80
0.00
0.00
W. II . Average
R. erythropolis Dioxygenase 29.25 15.01 47.40 41.33 35.22 0.00 26.69 23.10 0.00
SQ1 (pR4) Dehdyrogenase 9.69 0.00 18.29 59.58 58.10 0.00 49.50 41.20 0.00
14 M Average
R. erythropolis Dioxygenase 28.24 30.26 0.00 33.65 41.50 0.00 27.72 26.09 0.00
SQ1 (pR4-10) 26.16 24.60 0.00 41.90 49.00 0.00 78.90 43.50 0.00
6.97 6.36 0.00
Average
0.00
Appendix D: Dehydrogenase Enzyme Assay - The Styrene Glycol
Story
The analysis of the dehydrogenase substrate specificity led to testing of alternative substrates. A
compound similar to the indandiols and dihydro-naphthalenediol is styrene glycol.
OH
OH
R-Styrene Glycol
OH
K OH
S-Styrene Glycol
Figure C-1: Structure of Styrene Glycol
The structures of the two enantiomers of styrene glycol are shown.
Dehydrogenase enzyme assays, as described in Chapter Three, using both enantiomers of styrene
glycol as substrates were conducted. In addition, different buffer systems were analyzed for their effects
on the dehydrogenase assay. The strains analyzed include R. erythropolis SQ1 (pST1 17) expressing the
NidC dehydrogenase, and the control strain R. erythropolis SQ1 (pAPE1 2) containing an empty expression
vector. Each assay was repeated with three lysates. The results are shown in the table below. The pH of
the buffer had an effect on substrate range. That is, the R-styrene glycol could be used as a substrate
with a reaction buffer with a pH 9. Analysis of the control lysate, R. erythropolis SQ1 (pAPE1 2),
demonstrates that dehydrogenase activity that can use R-styrene glycol as a substrate is derived from the
host strain R. erythropolis SQ1, not from the NidC enzyme encoded on the plasmid pST1 17.
Furthermore, the R. erythropolis SQ1 dehydrogenase could be stereospecific as it is unable to use S-
styrene glycol as a substrate at pH 9. Further investigation is required.
100 mM K' Phosphate 100 mM K+ Phosphate 50 mM Tris-Propane,
Buffer Buffer 0.8 M NaCl
Compound pH 7.6 pH 9.15 pH 9.5
pST117 pAPE12 pST117 pAPE12 pST117 pAPE12
cis-(1 R,2S)-dihydro- + - + nd nd
naphthalenediol
cis-(1 R,2S)-indandiol + - nd nd nd nd
cis-(1 S,2R)-indandiol - - nd nd nd nd
R-styrene glycol -b nd + + + nd
S-styrene glycol b nd - nd nd nd
a nd, not determined
b assays conducted with and without NaCl
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Appendix E: Plasmid Instability
Rearrangement of plasmid DNA, especially large plasmids, is not uncommon. Plasmids and cosmids
containing DNA derived from Rhodococcus strain 124 exhibit some rearrangement capabilities.
Rearrangement was first encountered in the analysis of the cosmid clone pR4 and the subclone pR4-10.
When these plasmids are transformed into E. coli and the cells are grown to saturation in a volume larger
than 50 ml, the plasmids rearrange. Rearrangement was demonstrated by repeating the indigo formation
assay as described in Chapter Two. The resulting plates of E. coli(pR4) and E. coli(pR4-1 0) exhibited a
mixture of blue and white colonies. When the plasmid DNA content of the blue colonies and the white
colonies derived from E. coli(pR4-10) was analyzed by restriction enzyme digest, all of the blue colonies
produced one restriction pattern and all of the white colonies produced a second pattern. The same
results were obtained from the analysis of E. coli(pR4) derived colonies. Rearrangement of pR4 and pR4-
10 in E. coli can be prevented by growing 5 ml cultures. All initial analysis of the cosmids clones and
subclones was conducted with small cultures of this type which explains why in the initial analysis of the
cosmid clone and subclone that rearrangement was not detected at that time. Consequently, all large
scale DNA preps of these plasmids requires the pooling of multiple small scale preparations of DNA in
order to obtain a unique plasmid population.
Cosmid clones expressed in the host strain Rhodococcus erythropolis SQ1 also exhibit
rearrangement. This has not been seen with cosmid pR4 or pR4-1 0, but rather with other cosmid clones
from the Rhodococcus strain 124 cosmid library. Some cosmids when transformed into R. erythropolis
SQ1 undergo rearrangement. Once again the rearrangement was identified during analyses of plasmid
DNA extracted from the cells. The plasmid DNA was compared to plasmid DNA derived from E. coli via
restriction enzyme digest analysis. No pattern of rearrangement has been determined. Furthermore, in a
population of transformants rarely will every transformant analyzed produce rearranged plasmids.
Conjugation experiments with E. coli S1 7-1 to Rhodococcus strain 124 demonstrate that
rearrangement of plasmids can also occur in Rhodococcus strain 124 (P. Lessard and X. Shaver,
unpublished results). Approximately one out of every three transconjugants is rearranged. Interestingly,
the plasmid in this case is partially derived from another strain of Rhodococcus, Rhodococcus strain
B264-1.
It is unclear what is responsible for inducing plasmid instability. The G+C content of Rhodococci is
fairly high, approximately 65%. This could lead to regions that are highly similar that could undergo
spontaneous recombination at a certain frequency in a heterologous host. However, sequence analysis of
pR4-1 0 did not reveal any repeat regions that could contribute in this manner. It is also possible that all of
the strains used in these analyses (E. coli JM1 09 or DH5a, R. erythropolis SQ1, and Rhodococcus strain
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124) may contain a recomibinase or recombinase-like enzyme that recognizes something unique to
Rhodococcal DNA inducing plasmid instability. Further analysis of this phenomenon could be useful.
116
Appendix E: Plasmid Maps
The following pages contain the maps for plasmids constructed for this work. This information is meant to
be a permanent record to facilitate the work of others who may continue with this project.
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coRi 1
BamH1 10
Sal 1 16
Hincll 16
PstI 22
spH 98hol 178
Cla 1 270
Hindlll 274
Smal 452
Ncol 255Sspl 503Ncol 557 vul 577
BgI 1 2431
Afl 1 1 240 p EP2 KanR indill 698
3110 bp se 1 778
NG2 ori
Mlul 2007
Hindill 198
tul(d) 1202
Bst~ll 1Ncol 1261
BKtnI 18 Pvull 1291
Kpncl 1797 BspHI 1498 naBI 1306Hici 19Stul 1669 SnaBI 1334
Dral 1662
Plasmid name: pEP2
Plasmid size: 3110 bp
Constructed by: Adrian Hodgson, CSIRO
Construction date:
Comments/References: Received from A.J. Pittard, University of Melbourne;
Kanamycin resistance marker derived from pUC4K; origin of replication derived from
NG2; replicates well in E. coli, Corynebacterium and in Rhodococcus
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Eco RI 1
ot I 7
Bam HI 32
Not 1 57
Eco RI 65
Pst 1 6791la19
Dra 1I1 676 Aat I 723
Xho I 6 5 st XI 413
Cal I6439
Sma 1 6361
Eco NI 6320
Pvu 1 6236 COS Nhe 1 1155
Ase 1 60 KanR ba 1 1171
t XI 1494
pRhodoCOS
Pvu Ps 55 ori 7313 bp 
Kpn y5004 rep
SV40
Bal o 4396 Pst 3022
Bal 1 4154 Sh31 3101
Sfi 1 3303
Eco RI 3702 Pvu 11 3601
Plasmid name: pRhodoCOS
Plasmid size: 7313 bp
Constructed by: Sheri Treadway
Construction date: 6 August 1997
Comments/References: Constructed by replacing the origin and selectable marker
in SuperCOS with those from pEP2; pEP2 ligated as a BamHl-Sall (blunted) fragment
into the Bglll-Scal sites of SuperCOS; should replicate in both E. coli and Rhodococcus;
KanR
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co47 111 494
RP4 mob i
NG2 Origin at 11 1298
pST107 palI 1549 Xmnl 1617
7023 bp cal 1738
Plac Pstl 1975
- KanR
SacB Sacl 2338
Smal 436
Xhol 4091
Pstl 3933
Sall 3929
Xbal 3923
Plasmid name: pST107
Plasmid size: 7023 bp
Constructed by: S. Treadway
Construction date: Jan 1998
Comments/References: pAL226 cut with PstI ligated with a Pstl fragment from
pWS1 carrying the sacB gene under control of the lac promoter. Cloning sites: Sall,
Xbal, Scal, ApaLl, Apal.
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M
inDIII 0.23
,.4 pnl 0.24
Sacl 0.25
amHI 0.25-
Spel 0.26
coRl 0.28
Sp6 pr coRV 0.67
3' Downstream Dehydrogenase Region
pST108
6.40 Kb
- otl 1.59
AmpR -,coRl 1.60
Scal4.61EcoRV 1.61
-- tuPstt 1.61
Ncol 4.26 date:3/1' Upstream region E
KanR T7 pr Nsil 1.64
Pstl 3.97
Xbal 2.75
Plasmid name: pST108
Plasmid size: 6.40 kb
Constructed by: S.Treadway
Construction date: 3/12/98
Comments/References: pST114 cut with Xba and Nsi. Insert is an Xba-Nsi fragment
from pST112. Sizes are approximate.
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HindiII.Kpn.Sacl.BamHI.Spel.Eagl.EcoRI.Spe
coRV 0.67
Sp6 pr 3' downstream Dehydrogenase Region
Scal 5.75 AmpR 
pST109
7.54 Kb
Ncol 5.40 ts
KanR
Pstl 5.01T7p
Nsil 2.78
5' upstream region
Xbal 3.89
Plasmid name: pST109
Plasmid size: 7.54 kb
Constructed by: S. Treadway
Construction date: 3/18/98
Comments/References: pST108 cut with Notl and Nsil with a 1.14 Kb Bsp120l-PstI
insert from pAL231 contianing the tsr gene (thiostrepton). Preliminary Dehydrogenase
knock-out construct. Positions of antibiotic genes are appoximate.
122
EcoRl 1
HindIll 4701
RP4 mob
NG2 ori
HindIll 394 pST110
5063 bp
BstEll 3774 Aat 1 1298
KMR Sca 1 1738
Pstl 1975
Xhol 2131
Hindlll 2651 Smal 2405
Plasmid name: pST110
Plasmid size: 5063 bp
Constructed by: S. Treadway
Construction date: Jan 1998
Comments/References: Derivative of pAL226 with the BamHI site removed using
Klenow and filling in.
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coRI 1
at 11 1298
RP4 mob coRl 1377
otl 1383
NG2 ori amHI 1408
otl 1433
p ST1 11 coRl 1441
7486 bp
KanR
Cos Xbal 2547
Xhol 4554
Pstl 4398
Plasmid name: pST111
Plasmid size: 7486 bp
Constructed by: S. Treadway
Construction date: Jan 1998
Comments/References: pST110 cut with AatIl and Pstl. Insert is a 3.2 kb AatIl-PstI
fragment from pRhodoCOS containing the COS sites and BamHI site for cosmid cloning.
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ni 0.242
Sp6 pr aHl 0.25
Spel 0.26
agl 0.27
pnl 0.72 coRI 0.28
5'Upstream Dehydrogenas
pSa T12
5.00 Kb
AmpR T7 pr Ncol 1.34
Scal 3.51
EcoRl 1.40-
PstC 1.41
KanR EcoRV 1.41
Eagl 1.42
Ncol 2.96 Nsil 1.44
Pstl 2.57 
Xbal 1.45
Plasmid name: pST1 12
Plasmid size: 5.00 kb
Constructed by: S.Treadway
Construction date: 2/14/98
Comments/References: pCR2.1-Topo (Invitrogen) with 1.1 kb PCR fragment of
5' Upstream Region from R4 dehydrogenase using primers DH-1 and DH-2.
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inDlil 0.23
Pn 2.22
Xacl 0.25
amHl 0.25
Sp6 pr Spel 0.26
agl 0.27
coRl 0.28
pST113a 
co 0.29
5.40 Kb E.coli 
Tryptophanase st 0.90
AmpR
Scal 3.81 T7 pr
EcoR 1.68
KanR Pstl 1.70
EcoRV 1.71
Ncol 3.25 Eagl 1.72
Nsil 1.74
Pstl 2.80 Xbal 1.75
Plasmid name: pST1 13a
Plasmid size: 5.40 kb
Constructed by: S.Treadway
Construction date: 2/14/98
Comments/References: pCR2.1-Topo with 1.4 kb PCR fragment of E.coli Tryptophanse
with primers 5'TrpNco and 3'Trp. There is a pST113b which has the trp gene in the
opposite orientation. 113a Box 2 slot 78, 133b box 2 slot 79.
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in I 0.23
Sp6 pr amI0.25
Sacl 0.25
pel 0.26
agi 0.27
Spel 0.29 coRl 0.28
coRV 0.67
pST11 4 3' Downstream Dehydrogenase 
Region
AmpR 5.30 Kb T7 pr Notl 1.59
---- EcoRl 1.60
Scal 3.51 Pstl 1.61
KanR EcoRV 1.61
Eagl 1.62
Ncol 3.16 ' ,Nsil 1.64
Pstl 2.87 Xbal 1.65
Plasmid name: pST1 14
Plasmid size: 5.30 kb
Constructed by: S.Treadway
Construction date: 2/23/98
Comments/References: pCR2.1-Topo with -1.4 PCR fragment of 3' Downstream Region
from R4 dehydrogenase using primers DH-3 and DH-4. Site distances are approximate.
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Pvull 5496
EcoRV 5253 Pvull 5403 Ncol 265
Mlul 4805 lcq Pt rc Pstl 862
E.coli Tryptophnase
Sphl 436 pST1 15
5594 bp
EcoRI 1670
ori rrnB fragment Sacl 1676
T1 Kpnl 1682
T2 Smal 1686
AmpR BamHI 1691
Xbal 1697
Sall 1703
Pstl 1709
Bgl I 2909 Pvul 2661 Sphl 1715
HinDill 1721
Plasmid name: pST115
Plasmid size: 5594 bp
Constructed by: S. Treadway
Construction date: 3/6/98
Comments/References: E.coli Tryptophanase moved as an Nco I/EcoRi fragment
from pST113a, into the Ncol and EcoRi sites of pTRC99a.
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HinDIII.Kpni.BamHI.Sacl.Spel.Eagl.EcoRI
coRl 0.29
Sp6 pr
R4 Dehydrogenase
pST1 16a/b
5.00 Kb
BspHI 1.39
AmpR T7 pr EcoRl
Scal 3.51 PsRV
Eagl
KanR Ni
Ncol 2.96
Pstl 2.57
Plasmid name: pST1 16a/b
Plasmid size: 5.00 kb
Constructed by: S. Treadway
Construction date: 2/14/98
Comments/References: pCR2.1-Topo with 1.1 kb PCR fragment of the full length
R4 dehydrogenase using primers 5'-dehydro and 3'-dehydro. pST116b has the insert
in the opposite orientation of that shown above.
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coR1 1
PstI 894
R4 Dehydrogenase acil 1024
coRl 1050
Ptrc
pST117
5620 bp
EcoRV 1643
- laclq
Apal 1884
KanR
Pvul 3087 Dra 1I1 2554
Plasmid name: pST1 17
Plasmid size: 5620 bp
Constructed by: S. Treadway
Construction date: 4/8/98
Comments/References: pAPE12 cut with EcoRl and SAP treated. Insert from pST116a
cut with EcoR1. NOTE: pAPE12 was made by Avi Rhodal by cutting pEP2 with PstI and
Sall, inserting Ptrc as a Nsi-Sal fragment from pTRC99a.
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coRl 1
Pstl 894
R4 Dehydrogenase SacIl 1024
coRi 1050
pST118
6669 bp R4 Deh #2
Ptrc PstI 1943
KAnR SacIl 2073
laclq EcoR1 2099
Pvul 4136
EcoRV 2692
Dra 111 3603
Apal 2933
Plasmid name: pST118
Plasmid size: 6669 bp
Constructed by: S. Treadway
Construction date: 4/8/98
Comments/References: pAPE12 cut with EcoR1 and SAP treated. Insert from pST116a
cut with EcoR1. This plasmid has a double insert, in tandem.
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Spe 1 258
Spe 1 304
pal 410
coRV 872
V'end DEH
Scal 51
1 Amp ot/Bsp1201 1580
pST119
7413 bp
Tsr
EcoRV 2174
Pstl 4978 mob 5' end DEH
Xba 4960 Ndel 2678
Eco471ll 439 Pstl/Nsil 2721
Spe/Xba 3869
Plasmid name: pST1 19
Plasmid size: 7413 bp
Constructed by: S. Treadway
Construction date: April 1998
Comments/References: pST109 cut with PstI and Xbal. Insert is a Pstl-Spel
fragment from pAL235 containing the mobility element RP4. Plasmid contains colEl
ori only.
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M
PinDIII 234
1Spel 258
EcoR1 283
lul 932
BspHI 6160 Bsu321 1044
R4 Diox sm
Scal 5509 stBI 149
XmnI 5388 AmpR
7005 bp R4 Diox Ig s
KanRI 
2
Mlul 22
Miul 246
subunit
4
ubunit
207
10
5
Blpl(Espl) 2592
EcoRl 3398 EcoRi 2708
EcoRV 3408
Notl 3424
Nsil 3438
Xbal 3443
Apal 3449
Plasmid name: pST120
Plasmid size: 7005 bp
Constructed by: S.Treadway
Construction date: May 1998
Comments/References: PCR amplified large and small dioxygenase subunits from
pR4-10 using AP.21 and AP.23 primers. Cloned 3 kb fragment into pTopo2.1. 124 genomic
seq is bewteen EcoRI polylinker sites.
133
M
HD l1 234
pn I 240
Sac 1 246
amH tl252
pe1258
.vtX 1 272
Apa 11391
coRI 83Mlul 298
stPB 304
ColE1 ori p 8
BspH 1 406 SpecR tEll 937
Bga 1 377 pST1 214947 bp
Amp Espl 1318
Amp Mlul 1325
Pvu 1 3523 EcoR 11340
Sca 1 3412 Nsi 1 1341
C s c by S. 1 TPst 1 1346
n d: Ju 1KanR co R V 1350
Not 1 1366
Pvu 1 150 Xho 1 1373
Sph 1 28 BgU s 1530 Xba 1 1385
go p1 2260 Apa 1391
Nco 12856 Bcl 1 2265
Pst l 2473
Plasmid name: pST121
Plasmid size: 4947 bp
Constructed by: S. Treaadway
Construction date: June 1998
Comments/References: Used primers NSpec1 and CSpec1 to amplify specR gene
from pAPE1b. Cloned into pCR2.1-Topo plasmid from Invitrogen.
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HinDill 234
pil 240
apel 258
luA 935
stBIl 941
R4 sm subunit
AmpR pS T122 SpecR spi 1426
Xmn 1 4888 6505 bp
KAnR R4 Lg subuni Bsml 1851
Espl 1955
Bbvll 1975
MIul 1962
Espl 2092
Bglll3857Sall 2836
EcoRV 2908
NotU 2924-
Nsil 2938
Xbal 2943
Apal 2949
Plasmid name: pST122
Plasmid size: 6505 bp
Constructed by: S. Treadway
Construction date: June 1998
Comments/References: pST121 cut with Mlul removing spectinamycin gene. pST120
cut with Mlul and SAP treated. Origin: colEl.
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PinDIII 234
KpnI 240
Spel 258
Mlul 935
stBI 941
R4 sm subunit
spl 1426
Xmn 1 600 AmpR pS13 SpecR si15pST123 si15
7618 bp
R4 Lg subunit Espl 1955
KanRMlul- 1962
BbvII 1975
Espl 2092
BgIlIl 4970 Mob
Sall 2836
EcoRV 2908
Notl 2924
Apal 4062 Xbal 2965
Spe/Xba 4057
Plasmid name: pST123
Plasmid size: 7618 bp
Constructed by: S. Treadway
Construction date: June 1998
Comments/References: pST122 cut with Notl and Xba. Insert is a Spel-Noti
fragment of pAL235 containing the mob element. Contains two spec gene insertions,
in tandem.
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M
PinDIII 234
KpnI 240
Spel 258
lul 935
stB1 941
R4 sm subunit
spl 1426
pST124 sm 1851
7618 bp
R4 Lg subunit EspI 1955
KanR Mlul 1962
BbvII 1975
BgIll 4970 MEspI 2092
Sall 2836
EcoRV 2908
Notl 2924
Apal 4062 Xbal 2965
Spe/Xba 4057
Plasmid name: pST124
Plasmid size: 7618 bp
Constructed by: S. Treadway
Construction date: June 1998
Comments/References: pST122 cut with Notl and Xbal. Insert is a Spel-Notl
fragment of pAL235 containing the mob element. Knock-out construct of R4 dioxygenase.
Origin: colEl.
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EcoRI 1 Notl 7
amIH3 32
Aat l 786 Notl 57
Pvul 731 coR3665
Clal 90
bal 1171
SuperCOS
7937 bp
Pvull 4723 Sph 3101
Smal 469 Sphl 3173
Ncol 4289 Pvull 360 Ncol 3264
Sphl 4258 Bgl 11 3693 HinDill 3373Bal 1 3937
Pvull 3961
Plasmid name: SuperCOS
Plasmid size: 7937 bp
Constructed by: Strategene
Construction date: ?
Comments/References: Used to obtain COS sites for new cosmid vector pRhodoCOS.
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